BNX13的个人主页 - 老虎社区

BNX13

BNX13

Hello...!~

IP属地：未知

67关注

25粉丝

0主题

0勋章

2021-11-23

Pls like

抱歉，原内容已删除

2021-11-26

Pls like

抱歉，原内容已删除

2021-11-16

Pls like

Report says drugmakers impose unjustified U.S. price increases; spending on AbbVie drug rises $1.4 billion<blockquote>报告称制药商不合理地提高美国价格；艾伯维药物支出增加 14 亿美元</blockquote>

2021-11-08

Like pls

抱歉，原内容已删除

2021-11-04

Pls 👍

抱歉，原内容已删除

2021-11-19

Pls like

5 Stocks To Watch For November 19, 2021<blockquote>2021 年 11 月 19 日值得关注的 5 只股票</blockquote>

2021-11-08

Like pls

抱歉，原内容已删除

2021-11-08

Like pls

抱歉，原内容已删除

2021-11-23

Pls like

抱歉，原内容已删除

2021-11-19

Wow

5 Stocks To Watch For November 19, 2021<blockquote>2021 年 11 月 19 日值得关注的 5 只股票</blockquote>

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4098068058321510","uuid":"4098068058321510","gmtCreate":1634964992382,"gmtModify":1635070912655,"name":"BNX13","pinyin":"bnx13","introduction":"","introductionEn":null,"signature":"Hello...!~","avatar":"https://static.tigerbbs.com/5d3344dbee36ba1a93ce6095b9a6a82b","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":25,"headSize":67,"tweetSize":47,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.04.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.30","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.30","exceedPercentage":"60.43%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":877233849,"gmtCreate":1637933843875,"gmtModify":1637933844001,"author":{"id":"4098068058321510","authorId":"4098068058321510","name":"BNX13","avatar":"https://static.tigerbbs.com/5d3344dbee36ba1a93ce6095b9a6a82b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098068058321510","idStr":"4098068058321510"},"themes":[],"title":"","htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/877233849","repostId":"2186488363","repostType":4,"isVote":1,"tweetType":1,"viewCount":3377,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874454179,"gmtCreate":1637815107718,"gmtModify":1637815107846,"author":{"id":"4098068058321510","authorId":"4098068058321510","name":"BNX13","avatar":"https://static.tigerbbs.com/5d3344dbee36ba1a93ce6095b9a6a82b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098068058321510","idStr":"4098068058321510"},"themes":[],"title":"","htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/874454179","repostId":"2186364091","repostType":4,"isVote":1,"tweetType":1,"viewCount":3245,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875893833,"gmtCreate":1637629959719,"gmtModify":1637629959820,"author":{"id":"4098068058321510","authorId":"4098068058321510","name":"BNX13","avatar":"https://static.tigerbbs.com/5d3344dbee36ba1a93ce6095b9a6a82b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098068058321510","idStr":"4098068058321510"},"themes":[],"title":"","htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/875893833","repostId":"1122322848","repostType":4,"isVote":1,"tweetType":1,"viewCount":3720,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875899520,"gmtCreate":1637629902112,"gmtModify":1637629902224,"author":{"id":"4098068058321510","authorId":"4098068058321510","name":"BNX13","avatar":"https://static.tigerbbs.com/5d3344dbee36ba1a93ce6095b9a6a82b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098068058321510","idStr":"4098068058321510"},"themes":[],"title":"","htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875899520","repostId":"2185129808","repostType":4,"isVote":1,"tweetType":1,"viewCount":3644,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875890677,"gmtCreate":1637629806755,"gmtModify":1637629806863,"author":{"id":"4098068058321510","authorId":"4098068058321510","name":"BNX13","avatar":"https://static.tigerbbs.com/5d3344dbee36ba1a93ce6095b9a6a82b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098068058321510","idStr":"4098068058321510"},"themes":[],"title":"","htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/875890677","repostId":"1192554686","repostType":4,"repost":{"id":"1192554686","kind":"news","pubTimestamp":1637629334,"share":"https://www.laohunote.com/m/news/1192554686?lang=zh_CN&edition=full","pubTime":"2021-11-23 09:02","market":"us","language":"en","title":"Samsung to Choose Taylor, Texas, for $17 Billion Chipmaking Factory<blockquote>三星将选择德克萨斯州泰勒建造价值 170 亿美元的芯片制造厂</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1192554686","media":"The Wall Street Journal","summary":"The announcement is expected at Tuesday event to be attended by Texas Gov. Greg Abbott, sources say\n","content":"<p>The announcement is expected at Tuesday event to be attended by Texas Gov. Greg Abbott, sources say</p><p><blockquote>消息人士称，德克萨斯州州长格雷格·阿博特预计将在周二的活动中宣布这一消息</blockquote></p><p> Samsung&nbsp;Electronics Co. plans to&nbsp;build a roughly $17 billion chip-making plant&nbsp;in Taylor, Texas, according to people familiar with the matter, a mega investment by the South Korean tech giant, as the Biden administration pushes for an expansion of U.S. semiconductor production.</p><p><blockquote>据知情人士透露，三星电子公司计划在德克萨斯州泰勒建造一座价值约 170 亿美元的芯片制造厂，这是这家韩国科技巨头在拜登政府推动扩大美国半导体生产之际进行的一项巨额投资。</blockquote></p><p> An announcement could come as early as Tuesday, people familiar with the matter said. Gov. Greg Abbott is scheduled to make an “economic announcement” Tuesday at 5 p.m. local time.</p><p><blockquote>知情人士称，最早可能在周二发布公告。州长格雷格-阿博特（Greg Abbott）定于当地时间周二下午 5 点发表 “经济声明”。</blockquote></p><p> The Taylor facility, located in central Texas, plans to create around 1,800 jobs, though chip production is not expected to start until the end of 2024, according to documents Samsung had previously filed with Texas authorities. To woo Samsung, Taylor had offered incentives that include the equivalent of property-tax breaks of up to 92.5% for the first 10 years, with the write-offs gradually declining over the next several decades.</p><p><blockquote>根据三星此前向德克萨斯州当局提交的文件，位于德克萨斯州中部的泰勒工厂计划创造约 1,800 个就业岗位，但芯片生产预计要到 2024 年底才会开始。为了吸引三星，泰勒提供了激励措施，其中包括前 10 年高达 92.5% 的财产税减免，并在接下来的几十年里逐渐减少。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Samsung to Choose Taylor, Texas, for $17 Billion Chipmaking Factory<blockquote>三星将选择德克萨斯州泰勒建造价值 170 亿美元的芯片制造厂</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSamsung to Choose Taylor, Texas, for $17 Billion Chipmaking Factory<blockquote>三星将选择德克萨斯州泰勒建造价值 170 亿美元的芯片制造厂</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">The Wall Street Journal</strong><span class=\"h-time small\">2021-11-23 09:02</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The announcement is expected at Tuesday event to be attended by Texas Gov. Greg Abbott, sources say</p><p><blockquote>消息人士称，德克萨斯州州长格雷格·阿博特预计将在周二的活动中宣布这一消息</blockquote></p><p> Samsung&nbsp;Electronics Co. plans to&nbsp;build a roughly $17 billion chip-making plant&nbsp;in Taylor, Texas, according to people familiar with the matter, a mega investment by the South Korean tech giant, as the Biden administration pushes for an expansion of U.S. semiconductor production.</p><p><blockquote>据知情人士透露，三星电子公司计划在德克萨斯州泰勒建造一座价值约 170 亿美元的芯片制造厂，这是这家韩国科技巨头在拜登政府推动扩大美国半导体生产之际进行的一项巨额投资。</blockquote></p><p> An announcement could come as early as Tuesday, people familiar with the matter said. Gov. Greg Abbott is scheduled to make an “economic announcement” Tuesday at 5 p.m. local time.</p><p><blockquote>知情人士称，最早可能在周二发布公告。州长格雷格-阿博特（Greg Abbott）定于当地时间周二下午 5 点发表 “经济声明”。</blockquote></p><p> The Taylor facility, located in central Texas, plans to create around 1,800 jobs, though chip production is not expected to start until the end of 2024, according to documents Samsung had previously filed with Texas authorities. To woo Samsung, Taylor had offered incentives that include the equivalent of property-tax breaks of up to 92.5% for the first 10 years, with the write-offs gradually declining over the next several decades.</p><p><blockquote>根据三星此前向德克萨斯州当局提交的文件，位于德克萨斯州中部的泰勒工厂计划创造约 1,800 个就业岗位，但芯片生产预计要到 2024 年底才会开始。为了吸引三星，泰勒提供了激励措施，其中包括前 10 年高达 92.5% 的财产税减免，并在接下来的几十年里逐渐减少。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.wsj.com/articles/samsung-to-choose-taylor-texas-for-17-billion-chipmaking-factory-11637627613?mod=hp_lista_pos2\">The Wall Street Journal</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SSNLF":"三星电子"},"source_url":"https://www.wsj.com/articles/samsung-to-choose-taylor-texas-for-17-billion-chipmaking-factory-11637627613?mod=hp_lista_pos2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1192554686","content_text":"The announcement is expected at Tuesday event to be attended by Texas Gov. Greg Abbott, sources say\nSamsung Electronics Co. plans to build a roughly $17 billion chip-making plant in Taylor, Texas, according to people familiar with the matter, a mega investment by the South Korean tech giant, as the Biden administration pushes for an expansion of U.S. semiconductor production.\nAn announcement could come as early as Tuesday, people familiar with the matter said. Gov. Greg Abbott is scheduled to make an “economic announcement” Tuesday at 5 p.m. local time.\nThe Taylor facility, located in central Texas, plans to create around 1,800 jobs, though chip production is not expected to start until the end of 2024, according to documents Samsung had previously filed with Texas authorities. To woo Samsung, Taylor had offered incentives that include the equivalent of property-tax breaks of up to 92.5% for the first 10 years, with the write-offs gradually declining over the next several decades.","news_type":1,"symbols_score_info":{"SSNLF":0.9}},"isVote":1,"tweetType":1,"viewCount":3097,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875804233,"gmtCreate":1637629702255,"gmtModify":1637629702403,"author":{"id":"4098068058321510","authorId":"4098068058321510","name":"BNX13","avatar":"https://static.tigerbbs.com/5d3344dbee36ba1a93ce6095b9a6a82b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098068058321510","idStr":"4098068058321510"},"themes":[],"title":"","htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/875804233","repostId":"2185306806","repostType":4,"isVote":1,"tweetType":1,"viewCount":4048,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876644209,"gmtCreate":1637312431986,"gmtModify":1637312432133,"author":{"id":"4098068058321510","authorId":"4098068058321510","name":"BNX13","avatar":"https://static.tigerbbs.com/5d3344dbee36ba1a93ce6095b9a6a82b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098068058321510","idStr":"4098068058321510"},"themes":[],"title":"","htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876644209","repostId":"1199605105","repostType":4,"repost":{"id":"1199605105","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga Earnings","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1637311720,"share":"https://www.laohunote.com/m/news/1199605105?lang=zh_CN&edition=full","pubTime":"2021-11-19 16:48","market":"us","language":"en","title":"5 Stocks To Watch For November 19, 2021<blockquote>2021 年 11 月 19 日值得关注的 5 只股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1199605105","media":"Benzinga Earnings","summary":"Some of the stocks that may grab investor focus today are:\n\nWall Street expects Foot Locker, Inc. to","content":"<p>Some of the stocks that may grab investor focus today are:</p><p><blockquote>今天可能吸引投资者关注的一些股票是：</blockquote></p><p> <ul>  <li>Wall Street expects&nbsp;<b>Foot Locker, Inc.</b>&nbsp;to report quarterly earnings at $1.37 per share on revenue of $2.12 billion before the opening bell. Foot Locker shares rose 3.2% to $59.40 in after-hours trading.</li>  <li><b>Intuit Inc.</b>&nbsp;reported better-than-expected results for its first quarter and issued strong forecast for FY22. Intuit shares jumped 9% to $685.50 in the after-hours trading session.</li>  <li><b>Ross Stores, Inc.</b>&nbsp;reported upbeat earnings for its third quarter, but issued weak earnings guidance for the current quarter. Ross Stores shares dropped 5% to $113.5 in the after-hours trading session.</li> </ul> <ul>  <li>Analysts are expecting&nbsp;<b>The Buckle, Inc.</b>&nbsp;to have earned $0.92 per share on revenue of $299.12 million in the recent quarter. The company will release earnings before the markets open. Buckle shares rose 0.5% to $54.04 in after-hours trading.</li>  <li><b>Workday, Inc.</b>&nbsp;posted stronger-than-expected earnings for its third quarter and announced intent to acquire VNDLY for $510 million. The company also said it sees Q4 subscription revenue of $1.216 billion to $1.218 billion. Workday shares dipped 8% to $275.10 in the after-hours trading session.</li> </ul></p><p><blockquote><ul><li>华尔街预期<b>脚柜公司。</b>开盘前公布季度收益为每股 1.37 美元，营收为 21.2 亿美元。Foot Locker 股价在盘后交易中上涨 3.2%，至 59.40 美元。</li><li><b>直觉公司。</b>公布第一季度业绩好于预期，并发布了 2022 财年的强劲预测。Intuit 股价在盘后交易时段上涨 9%，至 685.50 美元。</li><li><b>罗斯商店公司。</b>报告第三季度盈利乐观，但发布了本季度疲软的盈利指引。Ross Stores 股价在盘后交易时段下跌 5%，至 113.5 美元。</li></ul><ul><li>分析师预计<b>带扣公司。</b>最近一个季度每股收益 0.92 美元，营收为 2.9912 亿美元。该公司将在开盘前发布财报。Buckle 股价在盘后交易中上涨 0.5%，至 54.04 美元。</li><li><b>工作日公司。</b>公布第三季度收益强于预期，并宣布有意以 5.1 亿美元收购 VNDLY。该公司还表示，预计第四季度订阅收入将达到 12.16 亿美元至 12.18 亿美元。Workday 股价在盘后交易时段下跌 8%，至 275.10 美元。</li></ul></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks To Watch For November 19, 2021<blockquote>2021 年 11 月 19 日值得关注的 5 只股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks To Watch For November 19, 2021<blockquote>2021 年 11 月 19 日值得关注的 5 只股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga Earnings </p>\n<p class=\"h-time smaller\">2021-11-19 16:48</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p>Some of the stocks that may grab investor focus today are:</p><p><blockquote>今天可能吸引投资者关注的一些股票是：</blockquote></p><p> <ul>  <li>Wall Street expects&nbsp;<b>Foot Locker, Inc.</b>&nbsp;to report quarterly earnings at $1.37 per share on revenue of $2.12 billion before the opening bell. Foot Locker shares rose 3.2% to $59.40 in after-hours trading.</li>  <li><b>Intuit Inc.</b>&nbsp;reported better-than-expected results for its first quarter and issued strong forecast for FY22. Intuit shares jumped 9% to $685.50 in the after-hours trading session.</li>  <li><b>Ross Stores, Inc.</b>&nbsp;reported upbeat earnings for its third quarter, but issued weak earnings guidance for the current quarter. Ross Stores shares dropped 5% to $113.5 in the after-hours trading session.</li> </ul> <ul>  <li>Analysts are expecting&nbsp;<b>The Buckle, Inc.</b>&nbsp;to have earned $0.92 per share on revenue of $299.12 million in the recent quarter. The company will release earnings before the markets open. Buckle shares rose 0.5% to $54.04 in after-hours trading.</li>  <li><b>Workday, Inc.</b>&nbsp;posted stronger-than-expected earnings for its third quarter and announced intent to acquire VNDLY for $510 million. The company also said it sees Q4 subscription revenue of $1.216 billion to $1.218 billion. Workday shares dipped 8% to $275.10 in the after-hours trading session.</li> </ul></p><p><blockquote><ul><li>华尔街预期<b>脚柜公司。</b>开盘前公布季度收益为每股 1.37 美元，营收为 21.2 亿美元。Foot Locker 股价在盘后交易中上涨 3.2%，至 59.40 美元。</li><li><b>直觉公司。</b>公布第一季度业绩好于预期，并发布了 2022 财年的强劲预测。Intuit 股价在盘后交易时段上涨 9%，至 685.50 美元。</li><li><b>罗斯商店公司。</b>报告第三季度盈利乐观，但发布了本季度疲软的盈利指引。Ross Stores 股价在盘后交易时段下跌 5%，至 113.5 美元。</li></ul><ul><li>分析师预计<b>带扣公司。</b>最近一个季度每股收益 0.92 美元，营收为 2.9912 亿美元。该公司将在开盘前发布财报。Buckle 股价在盘后交易中上涨 0.5%，至 54.04 美元。</li><li><b>工作日公司。</b>公布第三季度收益强于预期，并宣布有意以 5.1 亿美元收购 VNDLY。该公司还表示，预计第四季度订阅收入将达到 12.16 亿美元至 12.18 亿美元。Workday 股价在盘后交易时段下跌 8%，至 275.10 美元。</li></ul></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"WDAY":"Workday","INTU":"财捷","ROST":"罗斯百货有限公司","BKE":"巴克尔"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1199605105","content_text":"Some of the stocks that may grab investor focus today are:\n\nWall Street expects Foot Locker, Inc. to report quarterly earnings at $1.37 per share on revenue of $2.12 billion before the opening bell. Foot Locker shares rose 3.2% to $59.40 in after-hours trading.\nIntuit Inc. reported better-than-expected results for its first quarter and issued strong forecast for FY22. Intuit shares jumped 9% to $685.50 in the after-hours trading session.\nRoss Stores, Inc. reported upbeat earnings for its third quarter, but issued weak earnings guidance for the current quarter. Ross Stores shares dropped 5% to $113.5 in the after-hours trading session.\n\n\nAnalysts are expecting The Buckle, Inc. to have earned $0.92 per share on revenue of $299.12 million in the recent quarter. The company will release earnings before the markets open. Buckle shares rose 0.5% to $54.04 in after-hours trading.\nWorkday, Inc. posted stronger-than-expected earnings for its third quarter and announced intent to acquire VNDLY for $510 million. The company also said it sees Q4 subscription revenue of $1.216 billion to $1.218 billion. Workday shares dipped 8% to $275.10 in the after-hours trading session.","news_type":1,"symbols_score_info":{"WDAY":0.9,"BKE":0.9,"INTU":0.9,"ROST":0.9,"FL":0.9}},"isVote":1,"tweetType":1,"viewCount":3034,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876645296,"gmtCreate":1637312299125,"gmtModify":1637312305513,"author":{"id":"4098068058321510","authorId":"4098068058321510","name":"BNX13","avatar":"https://static.tigerbbs.com/5d3344dbee36ba1a93ce6095b9a6a82b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098068058321510","idStr":"4098068058321510"},"themes":[],"title":"","htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/876645296","repostId":"1172525644","repostType":4,"repost":{"id":"1172525644","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga Earnings","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1637311086,"share":"https://www.laohunote.com/m/news/1172525644?lang=zh_CN&edition=full","pubTime":"2021-11-19 16:38","market":"us","language":"en","title":"Economic Data Scheduled For Friday<blockquote>定于周五公布的经济数据</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1172525644","media":"Benzinga Earnings","summary":"The Census Bureau quarterly services report for the third quarter is scheduled for release at 10:00 ","content":"<p><img src=\"https://static.tigerbbs.com/830168958ab2dfcb6a3f75e02bcb8c77\" tg-width=\"685\" tg-height=\"375\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> <ul>  <li>The Census Bureau quarterly services report for the third quarter is scheduled for release at 10:00 a.m. ET.</li>  <li>Federal Reserve Governor Christopher Waller is set to speak at 10:45 a.m. ET.</li>  <li>Federal Reserve Vice Chairman Richard Clarida will speak at 12:15 p.m. ET.</li>  <li>The Baker Hughes North American rig count report for the latest week will be released at 1:00 p.m. ET.</li> </ul></p><p><blockquote><ul><li>人口普查局第三季度季度服务报告定于美国东部时间上午10:00发布。</li><li>美联储理事克里斯托弗·沃勒定于美国东部时间上午 10:45 发表讲话。</li><li>美联储副主席理查德·克拉里达将于美国东部时间中午 12:15 发表讲话。</li><li>贝克休斯最近一周的北美钻机数量报告将于美国东部时间下午 1:00 发布。</li></ul></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Economic Data Scheduled For Friday<blockquote>定于周五公布的经济数据</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEconomic Data Scheduled For Friday<blockquote>定于周五公布的经济数据</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga Earnings </p>\n<p class=\"h-time smaller\">2021-11-19 16:38</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p><img src=\"https://static.tigerbbs.com/830168958ab2dfcb6a3f75e02bcb8c77\" tg-width=\"685\" tg-height=\"375\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> <ul>  <li>The Census Bureau quarterly services report for the third quarter is scheduled for release at 10:00 a.m. ET.</li>  <li>Federal Reserve Governor Christopher Waller is set to speak at 10:45 a.m. ET.</li>  <li>Federal Reserve Vice Chairman Richard Clarida will speak at 12:15 p.m. ET.</li>  <li>The Baker Hughes North American rig count report for the latest week will be released at 1:00 p.m. ET.</li> </ul></p><p><blockquote><ul><li>人口普查局第三季度季度服务报告定于美国东部时间上午10:00发布。</li><li>美联储理事克里斯托弗·沃勒定于美国东部时间上午 10:45 发表讲话。</li><li>美联储副主席理查德·克拉里达将于美国东部时间中午 12:15 发表讲话。</li><li>贝克休斯最近一周的北美钻机数量报告将于美国东部时间下午 1:00 发布。</li></ul></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1172525644","content_text":"The Census Bureau quarterly services report for the third quarter is scheduled for release at 10:00 a.m. ET.\nFederal Reserve Governor Christopher Waller is set to speak at 10:45 a.m. ET.\nFederal Reserve Vice Chairman Richard Clarida will speak at 12:15 p.m. ET.\nThe Baker Hughes North American rig count report for the latest week will be released at 1:00 p.m. ET.","news_type":1,"symbols_score_info":{".SPX":0.9,".DJI":0.9,".IXIC":0.9}},"isVote":1,"tweetType":1,"viewCount":4053,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876645820,"gmtCreate":1637312278645,"gmtModify":1637312278757,"author":{"id":"4098068058321510","authorId":"4098068058321510","name":"BNX13","avatar":"https://static.tigerbbs.com/5d3344dbee36ba1a93ce6095b9a6a82b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098068058321510","idStr":"4098068058321510"},"themes":[],"title":"","htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/876645820","repostId":"1199605105","repostType":4,"repost":{"id":"1199605105","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga Earnings","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1637311720,"share":"https://www.laohunote.com/m/news/1199605105?lang=zh_CN&edition=full","pubTime":"2021-11-19 16:48","market":"us","language":"en","title":"5 Stocks To Watch For November 19, 2021<blockquote>2021 年 11 月 19 日值得关注的 5 只股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1199605105","media":"Benzinga Earnings","summary":"Some of the stocks that may grab investor focus today are:\n\nWall Street expects Foot Locker, Inc. to","content":"<p>Some of the stocks that may grab investor focus today are:</p><p><blockquote>今天可能吸引投资者关注的一些股票是：</blockquote></p><p> <ul>  <li>Wall Street expects&nbsp;<b>Foot Locker, Inc.</b>&nbsp;to report quarterly earnings at $1.37 per share on revenue of $2.12 billion before the opening bell. Foot Locker shares rose 3.2% to $59.40 in after-hours trading.</li>  <li><b>Intuit Inc.</b>&nbsp;reported better-than-expected results for its first quarter and issued strong forecast for FY22. Intuit shares jumped 9% to $685.50 in the after-hours trading session.</li>  <li><b>Ross Stores, Inc.</b>&nbsp;reported upbeat earnings for its third quarter, but issued weak earnings guidance for the current quarter. Ross Stores shares dropped 5% to $113.5 in the after-hours trading session.</li> </ul> <ul>  <li>Analysts are expecting&nbsp;<b>The Buckle, Inc.</b>&nbsp;to have earned $0.92 per share on revenue of $299.12 million in the recent quarter. The company will release earnings before the markets open. Buckle shares rose 0.5% to $54.04 in after-hours trading.</li>  <li><b>Workday, Inc.</b>&nbsp;posted stronger-than-expected earnings for its third quarter and announced intent to acquire VNDLY for $510 million. The company also said it sees Q4 subscription revenue of $1.216 billion to $1.218 billion. Workday shares dipped 8% to $275.10 in the after-hours trading session.</li> </ul></p><p><blockquote><ul><li>华尔街预期<b>脚柜公司。</b>开盘前公布季度收益为每股 1.37 美元，营收为 21.2 亿美元。Foot Locker 股价在盘后交易中上涨 3.2%，至 59.40 美元。</li><li><b>直觉公司。</b>公布第一季度业绩好于预期，并发布了 2022 财年的强劲预测。Intuit 股价在盘后交易时段上涨 9%，至 685.50 美元。</li><li><b>罗斯商店公司。</b>报告第三季度盈利乐观，但发布了本季度疲软的盈利指引。Ross Stores 股价在盘后交易时段下跌 5%，至 113.5 美元。</li></ul><ul><li>分析师预计<b>带扣公司。</b>最近一个季度每股收益 0.92 美元，营收为 2.9912 亿美元。该公司将在开盘前发布财报。Buckle 股价在盘后交易中上涨 0.5%，至 54.04 美元。</li><li><b>工作日公司。</b>公布第三季度收益强于预期，并宣布有意以 5.1 亿美元收购 VNDLY。该公司还表示，预计第四季度订阅收入将达到 12.16 亿美元至 12.18 亿美元。Workday 股价在盘后交易时段下跌 8%，至 275.10 美元。</li></ul></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks To Watch For November 19, 2021<blockquote>2021 年 11 月 19 日值得关注的 5 只股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks To Watch For November 19, 2021<blockquote>2021 年 11 月 19 日值得关注的 5 只股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga Earnings </p>\n<p class=\"h-time smaller\">2021-11-19 16:48</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p>Some of the stocks that may grab investor focus today are:</p><p><blockquote>今天可能吸引投资者关注的一些股票是：</blockquote></p><p> <ul>  <li>Wall Street expects&nbsp;<b>Foot Locker, Inc.</b>&nbsp;to report quarterly earnings at $1.37 per share on revenue of $2.12 billion before the opening bell. Foot Locker shares rose 3.2% to $59.40 in after-hours trading.</li>  <li><b>Intuit Inc.</b>&nbsp;reported better-than-expected results for its first quarter and issued strong forecast for FY22. Intuit shares jumped 9% to $685.50 in the after-hours trading session.</li>  <li><b>Ross Stores, Inc.</b>&nbsp;reported upbeat earnings for its third quarter, but issued weak earnings guidance for the current quarter. Ross Stores shares dropped 5% to $113.5 in the after-hours trading session.</li> </ul> <ul>  <li>Analysts are expecting&nbsp;<b>The Buckle, Inc.</b>&nbsp;to have earned $0.92 per share on revenue of $299.12 million in the recent quarter. The company will release earnings before the markets open. Buckle shares rose 0.5% to $54.04 in after-hours trading.</li>  <li><b>Workday, Inc.</b>&nbsp;posted stronger-than-expected earnings for its third quarter and announced intent to acquire VNDLY for $510 million. The company also said it sees Q4 subscription revenue of $1.216 billion to $1.218 billion. Workday shares dipped 8% to $275.10 in the after-hours trading session.</li> </ul></p><p><blockquote><ul><li>华尔街预期<b>脚柜公司。</b>开盘前公布季度收益为每股 1.37 美元，营收为 21.2 亿美元。Foot Locker 股价在盘后交易中上涨 3.2%，至 59.40 美元。</li><li><b>直觉公司。</b>公布第一季度业绩好于预期，并发布了 2022 财年的强劲预测。Intuit 股价在盘后交易时段上涨 9%，至 685.50 美元。</li><li><b>罗斯商店公司。</b>报告第三季度盈利乐观，但发布了本季度疲软的盈利指引。Ross Stores 股价在盘后交易时段下跌 5%，至 113.5 美元。</li></ul><ul><li>分析师预计<b>带扣公司。</b>最近一个季度每股收益 0.92 美元，营收为 2.9912 亿美元。该公司将在开盘前发布财报。Buckle 股价在盘后交易中上涨 0.5%，至 54.04 美元。</li><li><b>工作日公司。</b>公布第三季度收益强于预期，并宣布有意以 5.1 亿美元收购 VNDLY。该公司还表示，预计第四季度订阅收入将达到 12.16 亿美元至 12.18 亿美元。Workday 股价在盘后交易时段下跌 8%，至 275.10 美元。</li></ul></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"WDAY":"Workday","INTU":"财捷","ROST":"罗斯百货有限公司","BKE":"巴克尔"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1199605105","content_text":"Some of the stocks that may grab investor focus today are:\n\nWall Street expects Foot Locker, Inc. to report quarterly earnings at $1.37 per share on revenue of $2.12 billion before the opening bell. Foot Locker shares rose 3.2% to $59.40 in after-hours trading.\nIntuit Inc. reported better-than-expected results for its first quarter and issued strong forecast for FY22. Intuit shares jumped 9% to $685.50 in the after-hours trading session.\nRoss Stores, Inc. reported upbeat earnings for its third quarter, but issued weak earnings guidance for the current quarter. Ross Stores shares dropped 5% to $113.5 in the after-hours trading session.\n\n\nAnalysts are expecting The Buckle, Inc. to have earned $0.92 per share on revenue of $299.12 million in the recent quarter. The company will release earnings before the markets open. Buckle shares rose 0.5% to $54.04 in after-hours trading.\nWorkday, Inc. posted stronger-than-expected earnings for its third quarter and announced intent to acquire VNDLY for $510 million. The company also said it sees Q4 subscription revenue of $1.216 billion to $1.218 billion. Workday shares dipped 8% to $275.10 in the after-hours trading session.","news_type":1,"symbols_score_info":{"WDAY":0.9,"BKE":0.9,"INTU":0.9,"ROST":0.9,"FL":0.9}},"isVote":1,"tweetType":1,"viewCount":2716,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871623706,"gmtCreate":1637066475459,"gmtModify":1637066475782,"author":{"id":"4098068058321510","authorId":"4098068058321510","name":"BNX13","avatar":"https://static.tigerbbs.com/5d3344dbee36ba1a93ce6095b9a6a82b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098068058321510","idStr":"4098068058321510"},"themes":[],"title":"","htmlText":"🐻🐨🐻‍❄️🐼","listText":"🐻🐨🐻‍❄️🐼","text":"🐻🐨🐻‍❄️🐼","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/871623706","repostId":"1185802687","repostType":4,"repost":{"id":"1185802687","kind":"news","pubTimestamp":1637047831,"share":"https://www.laohunote.com/m/news/1185802687?lang=zh_CN&edition=full","pubTime":"2021-11-16 15:30","market":"us","language":"en","title":"The S&P 500 PEG Ratio Is Low: Why It's A Bearish Sign<blockquote>标普500联系汇率较低：为什么这是一个看跌迹象</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1185802687","media":"Benzinga","summary":"The price-to-earnings-to-growth (PEG) ratio is a fundamental valuation metric that assesses a stock’","content":"<p><div> The price-to-earnings-to-growth (PEG) ratio is a fundamental valuation metric that assesses a stock’s price relative to its earnings and expected earnings growth rate. In theory, the lower the PEG, ...</p><p><blockquote><div>市盈率（PEG）是一个基本的估值指标，用于评估股票价格相对于其收益和预期收益增长率的关系。理论上，挂钩越低，...</div></blockquote></p><p>  <a href=\"https://finance.yahoo.com/news/p-500-peg-ratio-low-215508667.html\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://finance.yahoo.com/news/p-500-peg-ratio-low-215508667.html\">网页连接</a></blockquote></p><p></p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The S&P 500 PEG Ratio Is Low: Why It's A Bearish Sign<blockquote>标普500联系汇率较低：为什么这是一个看跌迹象</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe S&P 500 PEG Ratio Is Low: Why It's A Bearish Sign<blockquote>标普500联系汇率较低：为什么这是一个看跌迹象</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Benzinga</strong><span class=\"h-time small\">2021-11-16 15:30</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> The price-to-earnings-to-growth (PEG) ratio is a fundamental valuation metric that assesses a stock’s price relative to its earnings and expected earnings growth rate. In theory, the lower the PEG, ...</p><p><blockquote><div>市盈率（PEG）是一个基本的估值指标，用于评估股票价格相对于其收益和预期收益增长率的关系。理论上，挂钩越低，...</div></blockquote></p><p>  <a href=\"https://finance.yahoo.com/news/p-500-peg-ratio-low-215508667.html\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://finance.yahoo.com/news/p-500-peg-ratio-low-215508667.html\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/p-500-peg-ratio-low-215508667.html\">Benzinga</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index"},"source_url":"https://finance.yahoo.com/news/p-500-peg-ratio-low-215508667.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1185802687","content_text":"The price-to-earnings-to-growth (PEG) ratio is a fundamental valuation metric that assesses a stock’s price relative to its earnings and expected earnings growth rate. In theory, the lower the PEG, the more value a stock holds.\nThe S&P 500 currently has a forward PEG of just 1.11, 21% below its historical average. But Bank of America analyst Savita Subramanian said Monday that most fundamental valuation metrics suggest the stock market is overvalued, and the low PEG ratio may actually be just one more sign of irrational market exuberance.\nThe Numbers:Subramanian said the S&P 500 is statistically expensive based on 15 of 20 fundamental metrics he tracks, including a Shiller PE that’s 122.9% above historical norms and an S&P 500 Market Cap/GDP ratio that’s 170.3% above historical averages.\nIn fact, Subramanian said the only reason the S&P 500’s PEG is so low is because analysts have such high expectations for future earnings growth.\n“The attractive P/E to [long-term growth] ratio, or ‘PEG ratio,’ of the S&P 500 is due to lofty growth expectations, not low valuations,” he said.\nHigh Expectations:Analysts are currently projecting long-term S&P 500 earnings growth of 19%, even higher than peak dot-com bubble growth expectations. Like many economic and market sentiment measures, Subramanian said long-term growth expectations have historically been a better contrary indicator than positive indicator. In fact, of the 87 companies that had long-term earnings growth expectations back in 2000, only 15 actually delivered at least 20% LTG over the next five years, Subramanian said.\nLTG projections have historically had a negative 40% correlation to 12-month forward S&P 500 returns. If that correlation were to hold over the next 12 months, it would suggest about 20% downside for theSPDR S&P 500 ETF Trust(NYSE:SPY) by November 2022.\nBenzinga’s Take:Predicting market moves is far more complicated than analyzing one or even a handful of metrics, such as LTG projections or PEG. However, if 75% of Bank of America’s valuation metrics currently suggest stock valuations are historically high, investors should be prepared for the possibility of a steep correction if the Federal Reserve begins raising interest rates in 2022.","news_type":1,"symbols_score_info":{".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":5182,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871623245,"gmtCreate":1637066444028,"gmtModify":1637066444381,"author":{"id":"4098068058321510","authorId":"4098068058321510","name":"BNX13","avatar":"https://static.tigerbbs.com/5d3344dbee36ba1a93ce6095b9a6a82b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098068058321510","idStr":"4098068058321510"},"themes":[],"title":"","htmlText":"That is&nbsp;terrible","listText":"That is&nbsp;terrible","text":"That is terrible","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/871623245","repostId":"1112630891","repostType":4,"isVote":1,"tweetType":1,"viewCount":1295,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871629601,"gmtCreate":1637066332543,"gmtModify":1637066332912,"author":{"id":"4098068058321510","authorId":"4098068058321510","name":"BNX13","avatar":"https://static.tigerbbs.com/5d3344dbee36ba1a93ce6095b9a6a82b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098068058321510","idStr":"4098068058321510"},"themes":[],"title":"","htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/871629601","repostId":"1142799154","repostType":4,"repost":{"id":"1142799154","kind":"news","pubTimestamp":1637065694,"share":"https://www.laohunote.com/m/news/1142799154?lang=zh_CN&edition=full","pubTime":"2021-11-16 20:28","market":"us","language":"en","title":"Pfizer to allow generic versions of its COVID-19 pill in 95 countries<blockquote>辉瑞将在 95 个国家允许其 COVID-19 药丸的仿制药</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1142799154","media":"Reuters","summary":"Pfizer Inc(PFE.N)said on Tuesday it will allow generic manufacturers to supply its experimental anti","content":"<p>Pfizer Inc(PFE.N)said on Tuesday it will allow generic manufacturers to supply its experimental antiviral COVID-19 pill to 95 low- and middle-income countries through a licensing agreement with international public health group Medicines Patent Pool (MPP).</p><p><blockquote>辉瑞公司（PFE.N）周二表示，将通过与国际公共卫生组织药物专利池（MPP）达成许可协议，允许仿制药制造商向95个中低收入国家供应其实验性抗病毒COVID-19药丸。</blockquote></p><p> The voluntary licensing agreement between Pfizer and the MPP will allow the United Nations-backed group to grant sub-licenses to qualified generic drug manufacturers to make their own versions of PF-07321332. Pfizer will sell the pills it manufactures under the brand name Paxlovid.</p><p><blockquote>辉瑞和MPP之间的自愿许可协议将允许联合国支持的组织向合格的仿制药制造商授予再许可，以生产他们自己版本的PF-07321332。辉瑞将以Paxlovid品牌销售其生产的药片。</blockquote></p><p> Pfizer, which also makes one of the mostly widely used COVID-19 vaccines, has said the pill cut the chance of hospitalization or death for adults at risk of severe disease by 89% in its clinical trial.The drug will be used in combination with ritonavir, an HIV drug that is already available generically.</p><p><blockquote>辉瑞公司也生产最广泛使用的 COVID-19 疫苗之一，该公司表示，在其临床试验中，该药丸将有严重疾病风险的成年人住院或死亡的几率降低了 89%。该药物将与利托那韦联合使用，利托那韦是一种已经上市的艾滋病毒药物。</blockquote></p><p> Pfizer's licensing deal follows a similar arrangement by rival Merck &amp; Co(MRK.N)for generic manufacturing of its COVID-19 treatment. The deals are unusual arrangements that acknowledge the dire need for effective treatments as well as the pressure drugmakers are under to make their life saving drugs accessible at very low costs.</p><p><blockquote>辉瑞的许可协议是在竞争对手默克公司 (MRK.N) 就其 COVID-19 治疗药物的仿制药生产做出类似安排之后达成的。这些交易是不同寻常的安排，承认了对有效治疗的迫切需求，以及制药商面临的以非常低的成本提供救命药物的压力。</blockquote></p><p> \"We are extremely pleased to have another weapon in our armoury to protect people from the ravages of COVID-19,\" Charles Gore, Executive Director of the Medicines Patent Pool, said in an interview.</p><p><blockquote>药物专利池执行董事查尔斯·戈尔在接受采访时表示：“我们非常高兴我们的军械库中又多了一种武器，可以保护人们免受 COVID-19 的破坏。”</blockquote></p><p> Gore said he hoped the generic version of Pfizer's drug will be available within months.</p><p><blockquote>戈尔说，他希望辉瑞药物的仿制药能在几个月内上市。</blockquote></p><p> The 95 countries in the license agreement cover around 53% of the world's population and include all low- and lower-middle-income countries and some upper-middle-income countries in Sub-Saharan Africa. They also include countries that have transitioned from lower-middle to upper-middle-income status in the past five years, Pfizer and the MPP said.</p><p><blockquote>许可协议中的95个国家覆盖了世界人口的约53%，包括所有低收入和中低收入国家以及撒哈拉以南非洲的一些中上收入国家。辉瑞和MPP表示，它们还包括在过去五年中从中低收入过渡到中上收入的国家。</blockquote></p><p> \"We believe oral antiviral treatments can play a vital role in reducing the severity of COVID-19 infections... We must work to ensure that all people – regardless of where they live or their circumstances – have access to these breakthroughs,\" Pfizer Chief Executive Albert Bourla said in a statement.</p><p><blockquote>“我们相信口服抗病毒治疗可以在减轻 COVID-19 感染的严重程度方面发挥至关重要的作用……我们必须努力确保所有人——无论他们住在哪里或他们的情况如何——都能获得这些突破，”辉瑞首席执行官艾伯特·布尔拉在一份声明中说道。</blockquote></p><p> Pfizer will waive royalties on sales in low-income countries. It will also waive them in the other countries covered by the agreement as long as COVID-19 remains classified as a public health emergency of international concern by the World Health Organization.</p><p><blockquote>辉瑞将免除在低收入国家销售的特许权使用费。只要新冠肺炎仍然被世界卫生组织列为国际关注的突发公共卫生事件，它也将在协议涵盖的其他国家豁免它们。</blockquote></p><p> Pfizer's version of the drug will be in high demand. The company has said it expects to manufacture 180,000 treatment courses by the end of next month and at least 50 million courses by the end of 2022.</p><p><blockquote>辉瑞版本的药物需求量很大。该公司表示，预计到下月底生产 18 万个治疗疗程，到 2022 年底生产至少 5000 万个疗程。</blockquote></p><p> Even so, the drugmaker could be stretched trying to supply 47% of the world's population. A Pfizer executive said last week the market for the drug might be up to 150 million people and that many countries might also be interested in buying doses for their strategic reserves.</p><p><blockquote>即便如此，这家制药商在试图供应世界 47% 的人口时可能会捉襟见肘。辉瑞公司一位高管上周表示，该药物的市场可能多达 1.5 亿人，许多国家也可能有兴趣为其战略储备购买剂量。</blockquote></p><p> Pfizer has said it will sell the supply it produces using a tiered pricing approach based on the income level of each country. In the United States, it expects to price its treatment close to where Merck has priced its drug at around $700 a course.</p><p><blockquote>辉瑞公司表示，将根据每个国家的收入水平，采用分级定价方法销售其生产的药品。在美国，该公司预计其治疗价格将接近默克公司为其药物定价的水平，每个疗程约为 700 美元。</blockquote></p><p> Merck has license agreements for it COVID-19 pill, molnupiravir, in over 100 countries. Still, some international health officials said even that is not enough for the medicine to reach many in low- and middle-income countries in large enough numbers.</p><p><blockquote>默克公司在 100 多个国家拥有其 COVID-19 药丸 molnupiravir 的许可协议。尽管如此，一些国际卫生官员表示，即使这样也不足以让这种药物以足够大的数量到达中低收入国家的许多人手中。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer to allow generic versions of its COVID-19 pill in 95 countries<blockquote>辉瑞将在 95 个国家允许其 COVID-19 药丸的仿制药</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer to allow generic versions of its COVID-19 pill in 95 countries<blockquote>辉瑞将在 95 个国家允许其 COVID-19 药丸的仿制药</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Reuters</strong><span class=\"h-time small\">2021-11-16 20:28</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Pfizer Inc(PFE.N)said on Tuesday it will allow generic manufacturers to supply its experimental antiviral COVID-19 pill to 95 low- and middle-income countries through a licensing agreement with international public health group Medicines Patent Pool (MPP).</p><p><blockquote>辉瑞公司（PFE.N）周二表示，将通过与国际公共卫生组织药物专利池（MPP）达成许可协议，允许仿制药制造商向95个中低收入国家供应其实验性抗病毒COVID-19药丸。</blockquote></p><p> The voluntary licensing agreement between Pfizer and the MPP will allow the United Nations-backed group to grant sub-licenses to qualified generic drug manufacturers to make their own versions of PF-07321332. Pfizer will sell the pills it manufactures under the brand name Paxlovid.</p><p><blockquote>辉瑞和MPP之间的自愿许可协议将允许联合国支持的组织向合格的仿制药制造商授予再许可，以生产他们自己版本的PF-07321332。辉瑞将以Paxlovid品牌销售其生产的药片。</blockquote></p><p> Pfizer, which also makes one of the mostly widely used COVID-19 vaccines, has said the pill cut the chance of hospitalization or death for adults at risk of severe disease by 89% in its clinical trial.The drug will be used in combination with ritonavir, an HIV drug that is already available generically.</p><p><blockquote>辉瑞公司也生产最广泛使用的 COVID-19 疫苗之一，该公司表示，在其临床试验中，该药丸将有严重疾病风险的成年人住院或死亡的几率降低了 89%。该药物将与利托那韦联合使用，利托那韦是一种已经上市的艾滋病毒药物。</blockquote></p><p> Pfizer's licensing deal follows a similar arrangement by rival Merck &amp; Co(MRK.N)for generic manufacturing of its COVID-19 treatment. The deals are unusual arrangements that acknowledge the dire need for effective treatments as well as the pressure drugmakers are under to make their life saving drugs accessible at very low costs.</p><p><blockquote>辉瑞的许可协议是在竞争对手默克公司 (MRK.N) 就其 COVID-19 治疗药物的仿制药生产做出类似安排之后达成的。这些交易是不同寻常的安排，承认了对有效治疗的迫切需求，以及制药商面临的以非常低的成本提供救命药物的压力。</blockquote></p><p> \"We are extremely pleased to have another weapon in our armoury to protect people from the ravages of COVID-19,\" Charles Gore, Executive Director of the Medicines Patent Pool, said in an interview.</p><p><blockquote>药物专利池执行董事查尔斯·戈尔在接受采访时表示：“我们非常高兴我们的军械库中又多了一种武器，可以保护人们免受 COVID-19 的破坏。”</blockquote></p><p> Gore said he hoped the generic version of Pfizer's drug will be available within months.</p><p><blockquote>戈尔说，他希望辉瑞药物的仿制药能在几个月内上市。</blockquote></p><p> The 95 countries in the license agreement cover around 53% of the world's population and include all low- and lower-middle-income countries and some upper-middle-income countries in Sub-Saharan Africa. They also include countries that have transitioned from lower-middle to upper-middle-income status in the past five years, Pfizer and the MPP said.</p><p><blockquote>许可协议中的95个国家覆盖了世界人口的约53%，包括所有低收入和中低收入国家以及撒哈拉以南非洲的一些中上收入国家。辉瑞和MPP表示，它们还包括在过去五年中从中低收入过渡到中上收入的国家。</blockquote></p><p> \"We believe oral antiviral treatments can play a vital role in reducing the severity of COVID-19 infections... We must work to ensure that all people – regardless of where they live or their circumstances – have access to these breakthroughs,\" Pfizer Chief Executive Albert Bourla said in a statement.</p><p><blockquote>“我们相信口服抗病毒治疗可以在减轻 COVID-19 感染的严重程度方面发挥至关重要的作用……我们必须努力确保所有人——无论他们住在哪里或他们的情况如何——都能获得这些突破，”辉瑞首席执行官艾伯特·布尔拉在一份声明中说道。</blockquote></p><p> Pfizer will waive royalties on sales in low-income countries. It will also waive them in the other countries covered by the agreement as long as COVID-19 remains classified as a public health emergency of international concern by the World Health Organization.</p><p><blockquote>辉瑞将免除在低收入国家销售的特许权使用费。只要新冠肺炎仍然被世界卫生组织列为国际关注的突发公共卫生事件，它也将在协议涵盖的其他国家豁免它们。</blockquote></p><p> Pfizer's version of the drug will be in high demand. The company has said it expects to manufacture 180,000 treatment courses by the end of next month and at least 50 million courses by the end of 2022.</p><p><blockquote>辉瑞版本的药物需求量很大。该公司表示，预计到下月底生产 18 万个治疗疗程，到 2022 年底生产至少 5000 万个疗程。</blockquote></p><p> Even so, the drugmaker could be stretched trying to supply 47% of the world's population. A Pfizer executive said last week the market for the drug might be up to 150 million people and that many countries might also be interested in buying doses for their strategic reserves.</p><p><blockquote>即便如此，这家制药商在试图供应世界 47% 的人口时可能会捉襟见肘。辉瑞公司一位高管上周表示，该药物的市场可能多达 1.5 亿人，许多国家也可能有兴趣为其战略储备购买剂量。</blockquote></p><p> Pfizer has said it will sell the supply it produces using a tiered pricing approach based on the income level of each country. In the United States, it expects to price its treatment close to where Merck has priced its drug at around $700 a course.</p><p><blockquote>辉瑞公司表示，将根据每个国家的收入水平，采用分级定价方法销售其生产的药品。在美国，该公司预计其治疗价格将接近默克公司为其药物定价的水平，每个疗程约为 700 美元。</blockquote></p><p> Merck has license agreements for it COVID-19 pill, molnupiravir, in over 100 countries. Still, some international health officials said even that is not enough for the medicine to reach many in low- and middle-income countries in large enough numbers.</p><p><blockquote>默克公司在 100 多个国家拥有其 COVID-19 药丸 molnupiravir 的许可协议。尽管如此，一些国际卫生官员表示，即使这样也不足以让这种药物以足够大的数量到达中低收入国家的许多人手中。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-allow-generic-versions-its-covid-19-pill-95-countries-2021-11-16/\">Reuters</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-allow-generic-versions-its-covid-19-pill-95-countries-2021-11-16/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1142799154","content_text":"Pfizer Inc(PFE.N)said on Tuesday it will allow generic manufacturers to supply its experimental antiviral COVID-19 pill to 95 low- and middle-income countries through a licensing agreement with international public health group Medicines Patent Pool (MPP).\nThe voluntary licensing agreement between Pfizer and the MPP will allow the United Nations-backed group to grant sub-licenses to qualified generic drug manufacturers to make their own versions of PF-07321332. Pfizer will sell the pills it manufactures under the brand name Paxlovid.\nPfizer, which also makes one of the mostly widely used COVID-19 vaccines, has said the pill cut the chance of hospitalization or death for adults at risk of severe disease by 89% in its clinical trial.The drug will be used in combination with ritonavir, an HIV drug that is already available generically.\nPfizer's licensing deal follows a similar arrangement by rival Merck & Co(MRK.N)for generic manufacturing of its COVID-19 treatment. The deals are unusual arrangements that acknowledge the dire need for effective treatments as well as the pressure drugmakers are under to make their life saving drugs accessible at very low costs.\n\"We are extremely pleased to have another weapon in our armoury to protect people from the ravages of COVID-19,\" Charles Gore, Executive Director of the Medicines Patent Pool, said in an interview.\nGore said he hoped the generic version of Pfizer's drug will be available within months.\nThe 95 countries in the license agreement cover around 53% of the world's population and include all low- and lower-middle-income countries and some upper-middle-income countries in Sub-Saharan Africa. They also include countries that have transitioned from lower-middle to upper-middle-income status in the past five years, Pfizer and the MPP said.\n\"We believe oral antiviral treatments can play a vital role in reducing the severity of COVID-19 infections... We must work to ensure that all people – regardless of where they live or their circumstances – have access to these breakthroughs,\" Pfizer Chief Executive Albert Bourla said in a statement.\nPfizer will waive royalties on sales in low-income countries. It will also waive them in the other countries covered by the agreement as long as COVID-19 remains classified as a public health emergency of international concern by the World Health Organization.\nPfizer's version of the drug will be in high demand. The company has said it expects to manufacture 180,000 treatment courses by the end of next month and at least 50 million courses by the end of 2022.\nEven so, the drugmaker could be stretched trying to supply 47% of the world's population. A Pfizer executive said last week the market for the drug might be up to 150 million people and that many countries might also be interested in buying doses for their strategic reserves.\nPfizer has said it will sell the supply it produces using a tiered pricing approach based on the income level of each country. In the United States, it expects to price its treatment close to where Merck has priced its drug at around $700 a course.\nMerck has license agreements for it COVID-19 pill, molnupiravir, in over 100 countries. Still, some international health officials said even that is not enough for the medicine to reach many in low- and middle-income countries in large enough numbers.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":1086,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871629815,"gmtCreate":1637066315682,"gmtModify":1637066315988,"author":{"id":"4098068058321510","authorId":"4098068058321510","name":"BNX13","avatar":"https://static.tigerbbs.com/5d3344dbee36ba1a93ce6095b9a6a82b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098068058321510","idStr":"4098068058321510"},"themes":[],"title":"","htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/871629815","repostId":"1115914926","repostType":4,"repost":{"id":"1115914926","kind":"news","pubTimestamp":1637065849,"share":"https://www.laohunote.com/m/news/1115914926?lang=zh_CN&edition=full","pubTime":"2021-11-16 20:30","market":"us","language":"en","title":"Report says drugmakers impose unjustified U.S. price increases; spending on AbbVie drug rises $1.4 billion<blockquote>报告称制药商不合理地提高美国价格；艾伯维药物支出增加 14 亿美元</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1115914926","media":"Reuters","summary":"Drugmakers hiked U.S. prices on seven of the 10 costliest prescription drugs in 2020 without justifi","content":"<p>Drugmakers hiked U.S. prices on seven of the 10 costliest prescription drugs in 2020 without justification, increasing drug spending by $1.67 billion, a U.S. group that reviews the value of medicines said on Tuesday.</p><p><blockquote>一个审查药品价值的美国组织周二表示，制药商在没有正当理由的情况下提高了 2020 年 10 种最昂贵处方药中 7 种的美国价格，使药品支出增加了 16.7 亿美元。</blockquote></p><p> AbbVie Inc's(ABBV.N)widely used Humira rheumatoid arthritis drug accounted for the majority of the spending increase, with a net price increase of 9.6% leading to an almost $1.4 billion increase in U.S. spending.</p><p><blockquote>艾伯维公司(ABBV.N)广泛使用的Humira类风湿性关节炎药物占据了支出增长的大部分，净价格上涨9.6%，导致美国支出增加近14亿美元。</blockquote></p><p> The Boston-based Institute for Clinical and Economic Review (ICER) said in a report that after reviewing published studies and input from drug manufacturers it found no evidence of new clinical benefits to justify the price hikes.</p><p><blockquote>总部位于波士顿的临床和经济评论研究所（ICER）在一份报告中表示，在审查了已发表的研究和药品制造商的意见后，没有发现新的临床益处的证据来证明价格上涨是合理的。</blockquote></p><p> \"Several of these treatments have been on the market for many years, with scant evidence that they are any more effective than we understood them to be years ago when they cost far less,\" said ICER Chief Medical Officer David Rind.</p><p><blockquote>ICER 首席医疗官 David Rind 表示：“其中一些治疗方法已经上市多年，几乎没有证据表明它们比我们多年前所了解的更有效，当时它们的成本要低得多。”</blockquote></p><p> \"The most extreme of these is Humira, with an ever-escalating U.S. price that contrasts starkly to its falling price in every country where Humira currently faces biosimilar competition,\" he said in a statement. Humira received U.S. regulatory approval in 2002.</p><p><blockquote>他在一份声明中表示：“其中最极端的是修美乐，美国的价格不断攀升，与修美乐目前面临生物仿制药竞争的每个国家的价格不断下降形成鲜明对比。”Humira 于 2002 年获得美国监管部门批准。</blockquote></p><p> AbbVie said in a response to ICER that the report lacked context because ICER does not perform full value assessments and excludes evidence from smaller patient populations.</p><p><blockquote>艾伯维在回复 ICER 时表示，该报告缺乏背景信息，因为 ICER 不进行完整的价值评估，并且排除了来自较小患者群体的证据。</blockquote></p><p> The findings come as President Joe Biden and Democrats in Congress attempt to push through legislation that would lower drug prices by allowing the federal government to negotiate drug payments by Medicare, which covers Americans aged 65 and older.</p><p><blockquote>这些发现出炉之际，乔·拜登总统和国会民主党人试图通过立法，允许联邦政府通过医疗保险谈判降低药品价格，医疗保险覆盖65岁及以上的美国人。</blockquote></p><p> The United States spends more than twice as much per person on drugs as other wealthy economies, about $1,500, for a total of around $350 billion in 2019.</p><p><blockquote>美国人均药品支出是其他富裕经济体的两倍多，约为1500美元，2019年总额约为3500亿美元。</blockquote></p><p> Novartis(NOVN.S)drug Promacta, which is used to treat the rare blood disorder severe aplastic anemia (SAA), saw the highest increase in net price at 14.1%, leading to a $100 million increase in U.S. spending.</p><p><blockquote>诺华（NOVN.S）用于治疗罕见血液疾病严重再生障碍性贫血（SAA）的药物Promacta净价涨幅最高，达到14.1%，导致美国支出增加1亿美元。</blockquote></p><p> Novartis said it takes a value-based pricing approach and that it provided ICER with significant new clinical and health economic data that the group did not take into account.</p><p><blockquote>诺华表示，它采用基于价值的定价方法，并向 ICER 提供了该集团没有考虑的重要新临床和健康经济数据。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Report says drugmakers impose unjustified U.S. price increases; spending on AbbVie drug rises $1.4 billion<blockquote>报告称制药商不合理地提高美国价格；艾伯维药物支出增加 14 亿美元</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nReport says drugmakers impose unjustified U.S. price increases; spending on AbbVie drug rises $1.4 billion<blockquote>报告称制药商不合理地提高美国价格；艾伯维药物支出增加 14 亿美元</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Reuters</strong><span class=\"h-time small\">2021-11-16 20:30</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Drugmakers hiked U.S. prices on seven of the 10 costliest prescription drugs in 2020 without justification, increasing drug spending by $1.67 billion, a U.S. group that reviews the value of medicines said on Tuesday.</p><p><blockquote>一个审查药品价值的美国组织周二表示，制药商在没有正当理由的情况下提高了 2020 年 10 种最昂贵处方药中 7 种的美国价格，使药品支出增加了 16.7 亿美元。</blockquote></p><p> AbbVie Inc's(ABBV.N)widely used Humira rheumatoid arthritis drug accounted for the majority of the spending increase, with a net price increase of 9.6% leading to an almost $1.4 billion increase in U.S. spending.</p><p><blockquote>艾伯维公司(ABBV.N)广泛使用的Humira类风湿性关节炎药物占据了支出增长的大部分，净价格上涨9.6%，导致美国支出增加近14亿美元。</blockquote></p><p> The Boston-based Institute for Clinical and Economic Review (ICER) said in a report that after reviewing published studies and input from drug manufacturers it found no evidence of new clinical benefits to justify the price hikes.</p><p><blockquote>总部位于波士顿的临床和经济评论研究所（ICER）在一份报告中表示，在审查了已发表的研究和药品制造商的意见后，没有发现新的临床益处的证据来证明价格上涨是合理的。</blockquote></p><p> \"Several of these treatments have been on the market for many years, with scant evidence that they are any more effective than we understood them to be years ago when they cost far less,\" said ICER Chief Medical Officer David Rind.</p><p><blockquote>ICER 首席医疗官 David Rind 表示：“其中一些治疗方法已经上市多年，几乎没有证据表明它们比我们多年前所了解的更有效，当时它们的成本要低得多。”</blockquote></p><p> \"The most extreme of these is Humira, with an ever-escalating U.S. price that contrasts starkly to its falling price in every country where Humira currently faces biosimilar competition,\" he said in a statement. Humira received U.S. regulatory approval in 2002.</p><p><blockquote>他在一份声明中表示：“其中最极端的是修美乐，美国的价格不断攀升，与修美乐目前面临生物仿制药竞争的每个国家的价格不断下降形成鲜明对比。”Humira 于 2002 年获得美国监管部门批准。</blockquote></p><p> AbbVie said in a response to ICER that the report lacked context because ICER does not perform full value assessments and excludes evidence from smaller patient populations.</p><p><blockquote>艾伯维在回复 ICER 时表示，该报告缺乏背景信息，因为 ICER 不进行完整的价值评估，并且排除了来自较小患者群体的证据。</blockquote></p><p> The findings come as President Joe Biden and Democrats in Congress attempt to push through legislation that would lower drug prices by allowing the federal government to negotiate drug payments by Medicare, which covers Americans aged 65 and older.</p><p><blockquote>这些发现出炉之际，乔·拜登总统和国会民主党人试图通过立法，允许联邦政府通过医疗保险谈判降低药品价格，医疗保险覆盖65岁及以上的美国人。</blockquote></p><p> The United States spends more than twice as much per person on drugs as other wealthy economies, about $1,500, for a total of around $350 billion in 2019.</p><p><blockquote>美国人均药品支出是其他富裕经济体的两倍多，约为1500美元，2019年总额约为3500亿美元。</blockquote></p><p> Novartis(NOVN.S)drug Promacta, which is used to treat the rare blood disorder severe aplastic anemia (SAA), saw the highest increase in net price at 14.1%, leading to a $100 million increase in U.S. spending.</p><p><blockquote>诺华（NOVN.S）用于治疗罕见血液疾病严重再生障碍性贫血（SAA）的药物Promacta净价涨幅最高，达到14.1%，导致美国支出增加1亿美元。</blockquote></p><p> Novartis said it takes a value-based pricing approach and that it provided ICER with significant new clinical and health economic data that the group did not take into account.</p><p><blockquote>诺华表示，它采用基于价值的定价方法，并向 ICER 提供了该集团没有考虑的重要新临床和健康经济数据。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.reuters.com/business/healthcare-pharmaceuticals/report-says-drugmakers-impose-unjustified-us-price-increases-spending-abbvie-2021-11-16/\">Reuters</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ABBV":"艾伯维公司"},"source_url":"https://www.reuters.com/business/healthcare-pharmaceuticals/report-says-drugmakers-impose-unjustified-us-price-increases-spending-abbvie-2021-11-16/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1115914926","content_text":"Drugmakers hiked U.S. prices on seven of the 10 costliest prescription drugs in 2020 without justification, increasing drug spending by $1.67 billion, a U.S. group that reviews the value of medicines said on Tuesday.\nAbbVie Inc's(ABBV.N)widely used Humira rheumatoid arthritis drug accounted for the majority of the spending increase, with a net price increase of 9.6% leading to an almost $1.4 billion increase in U.S. spending.\nThe Boston-based Institute for Clinical and Economic Review (ICER) said in a report that after reviewing published studies and input from drug manufacturers it found no evidence of new clinical benefits to justify the price hikes.\n\"Several of these treatments have been on the market for many years, with scant evidence that they are any more effective than we understood them to be years ago when they cost far less,\" said ICER Chief Medical Officer David Rind.\n\"The most extreme of these is Humira, with an ever-escalating U.S. price that contrasts starkly to its falling price in every country where Humira currently faces biosimilar competition,\" he said in a statement. Humira received U.S. regulatory approval in 2002.\nAbbVie said in a response to ICER that the report lacked context because ICER does not perform full value assessments and excludes evidence from smaller patient populations.\nThe findings come as President Joe Biden and Democrats in Congress attempt to push through legislation that would lower drug prices by allowing the federal government to negotiate drug payments by Medicare, which covers Americans aged 65 and older.\nThe United States spends more than twice as much per person on drugs as other wealthy economies, about $1,500, for a total of around $350 billion in 2019.\nNovartis(NOVN.S)drug Promacta, which is used to treat the rare blood disorder severe aplastic anemia (SAA), saw the highest increase in net price at 14.1%, leading to a $100 million increase in U.S. spending.\nNovartis said it takes a value-based pricing approach and that it provided ICER with significant new clinical and health economic data that the group did not take into account.","news_type":1,"symbols_score_info":{"ABBV":0.9}},"isVote":1,"tweetType":1,"viewCount":984,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871629130,"gmtCreate":1637066298042,"gmtModify":1637066298357,"author":{"id":"4098068058321510","authorId":"4098068058321510","name":"BNX13","avatar":"https://static.tigerbbs.com/5d3344dbee36ba1a93ce6095b9a6a82b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098068058321510","idStr":"4098068058321510"},"themes":[],"title":"","htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/871629130","repostId":"2183200781","repostType":4,"isVote":1,"tweetType":1,"viewCount":1019,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871629936,"gmtCreate":1637066283694,"gmtModify":1637066284006,"author":{"id":"4098068058321510","authorId":"4098068058321510","name":"BNX13","avatar":"https://static.tigerbbs.com/5d3344dbee36ba1a93ce6095b9a6a82b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098068058321510","idStr":"4098068058321510"},"themes":[],"title":"","htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/871629936","repostId":"1132647839","repostType":4,"repost":{"id":"1132647839","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637054732,"share":"https://www.laohunote.com/m/news/1132647839?lang=zh_CN&edition=full","pubTime":"2021-11-16 17:25","market":"us","language":"en","title":"Rivian rose nearly 5% in premarket trading and reached an all-time high at 157 dollars<blockquote>Rivian在盘前交易中上涨近5%，达到157美元的历史新高</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1132647839","media":"Tiger Newspress","summary":"Rivian rose nearly 5% in premarket trading and reached an all-time high at 157 dollars.The company a","content":"<p>Rivian&nbsp;rose&nbsp;nearly&nbsp;5%&nbsp;in&nbsp;premarket&nbsp;trading&nbsp;and&nbsp;reached&nbsp;an all-time high&nbsp;at&nbsp;157&nbsp;dollars.<img src=\"https://static.tigerbbs.com/0e8d2fab49c319b46fb405a0c160b85c\" tg-width=\"777\" tg-height=\"568\" width=\"100%\" height=\"auto\">The&nbsp;company&nbsp;and&nbsp;Amazon&nbsp;will build a second electric vehicle manufacturing plant in Georgia, USA, and has entered a later stage of discussion.</p><p><blockquote>Rivian在盘前交易中上涨近5%，达到157美元的历史高点。该公司和亚马逊将在美国佐治亚州建设第二家电动汽车制造厂，目前已进入后期讨论阶段。</blockquote></p><p> Previously, Rivian had built a factory in Normal, Illinois, USA, which produced the company's all-electric R1T pickup truck.</p><p><blockquote>此前，Rivian已经在美国伊利诺伊州的Normal建了一家工厂，生产该公司的全电动R1T皮卡。</blockquote></p><p> In late July, four people familiar with the matter said Rivian planned to build a second assembly plant in the United States. At the time, sources also said the company's second plant in the U.S. would produce not only its all-electric vehicles, but also batteries.</p><p><blockquote>7月下旬，四名知情人士称，Rivian计划在美国建设第二家组装厂。当时，消息人士还表示，该公司在美国的第二家工厂不仅将生产全电动汽车，还将生产电池。</blockquote></p><p> Documents obtained by foreign media show that the factory will include a 50GWh battery production facility and a product and technology center.</p><p><blockquote>外媒获得的文件显示，该工厂将包括一个50GWh电池生产设施以及一个产品和技术中心。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rivian rose nearly 5% in premarket trading and reached an all-time high at 157 dollars<blockquote>Rivian在盘前交易中上涨近5%，达到157美元的历史新高</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRivian rose nearly 5% in premarket trading and reached an all-time high at 157 dollars<blockquote>Rivian在盘前交易中上涨近5%，达到157美元的历史新高</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-16 17:25</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Rivian&nbsp;rose&nbsp;nearly&nbsp;5%&nbsp;in&nbsp;premarket&nbsp;trading&nbsp;and&nbsp;reached&nbsp;an all-time high&nbsp;at&nbsp;157&nbsp;dollars.<img src=\"https://static.tigerbbs.com/0e8d2fab49c319b46fb405a0c160b85c\" tg-width=\"777\" tg-height=\"568\" width=\"100%\" height=\"auto\">The&nbsp;company&nbsp;and&nbsp;Amazon&nbsp;will build a second electric vehicle manufacturing plant in Georgia, USA, and has entered a later stage of discussion.</p><p><blockquote>Rivian在盘前交易中上涨近5%，达到157美元的历史高点。该公司和亚马逊将在美国佐治亚州建设第二家电动汽车制造厂，目前已进入后期讨论阶段。</blockquote></p><p> Previously, Rivian had built a factory in Normal, Illinois, USA, which produced the company's all-electric R1T pickup truck.</p><p><blockquote>此前，Rivian已经在美国伊利诺伊州的Normal建了一家工厂，生产该公司的全电动R1T皮卡。</blockquote></p><p> In late July, four people familiar with the matter said Rivian planned to build a second assembly plant in the United States. At the time, sources also said the company's second plant in the U.S. would produce not only its all-electric vehicles, but also batteries.</p><p><blockquote>7月下旬，四名知情人士称，Rivian计划在美国建设第二家组装厂。当时，消息人士还表示，该公司在美国的第二家工厂不仅将生产全电动汽车，还将生产电池。</blockquote></p><p> Documents obtained by foreign media show that the factory will include a 50GWh battery production facility and a product and technology center.</p><p><blockquote>外媒获得的文件显示，该工厂将包括一个50GWh电池生产设施以及一个产品和技术中心。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RIVN":"Rivian Automotive, Inc.","AMZN":"亚马逊"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1132647839","content_text":"Rivian rose nearly 5% in premarket trading and reached an all-time high at 157 dollars.The company and Amazon will build a second electric vehicle manufacturing plant in Georgia, USA, and has entered a later stage of discussion.\nPreviously, Rivian had built a factory in Normal, Illinois, USA, which produced the company's all-electric R1T pickup truck.\nIn late July, four people familiar with the matter said Rivian planned to build a second assembly plant in the United States. At the time, sources also said the company's second plant in the U.S. would produce not only its all-electric vehicles, but also batteries.\nDocuments obtained by foreign media show that the factory will include a 50GWh battery production facility and a product and technology center.","news_type":1,"symbols_score_info":{"AMZN":0.9,"RIVN":0.9}},"isVote":1,"tweetType":1,"viewCount":1523,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871629005,"gmtCreate":1637066273742,"gmtModify":1637066274060,"author":{"id":"4098068058321510","authorId":"4098068058321510","name":"BNX13","avatar":"https://static.tigerbbs.com/5d3344dbee36ba1a93ce6095b9a6a82b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098068058321510","idStr":"4098068058321510"},"themes":[],"title":"","htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/871629005","repostId":"1194227549","repostType":4,"repost":{"id":"1194227549","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637053309,"share":"https://www.laohunote.com/m/news/1194227549?lang=zh_CN&edition=full","pubTime":"2021-11-16 17:01","market":"us","language":"en","title":"Netease jumped over 5% in premarket trading as the company will repurchase up to 3 billion US dollars of shares<blockquote>网易在盘前交易中上涨超过5%，因为该公司将回购高达30亿美元的股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1194227549","media":"Tiger Newspress","summary":"Netease jumped over 5% in premarket trading as the company will repurchase up to 3 billion US dollar","content":"<p>Netease jumped over 5% in premarket trading as the company&nbsp;will repurchase up to 3 billion US dollars of shares.<img src=\"https://static.tigerbbs.com/61e3152ea1cdeed59a202df6546c9326\" tg-width=\"769\" tg-height=\"565\" referrerpolicy=\"no-referrer\">NetEase's revenue in the third quarter was 22.2 billion yuan (RMB, the same below), a year-on-year increase of 18.9%; The net profit attributable to the mother was RMB 3.2 billion, up 6.1% year-on-year.</p><p><blockquote>网易在盘前交易中上涨超过5%，因为该公司将回购高达30亿美元的股票。网易第三季度营收为222亿元(人民币，下同)，同比增长18.9%；归母净利润32亿元，同比增长6.1%。</blockquote></p><p> In the third quarter, the net income of online game services was 15.9 billion yuan (about 2.5 billion US dollars), a year-on-year increase of 14.7%; The net income of NetEase Youdao (DAO) was 1.4 billion yuan, up 54.8% year-on-year.</p><p><blockquote>第三季度，网络游戏服务净营收为159亿元人民币（约合25亿美元），同比增长14.7%；网易有道（DAO）净收入14亿元，同比增长54.8%。</blockquote></p><p> At the same time,The board of directors has approved an increase in the amount of the share repurchase program to no more than $3 billion.</p><p><blockquote>与此同时， 董事会已批准将股票回购计划金额增加至不超过30亿美元。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Netease jumped over 5% in premarket trading as the company will repurchase up to 3 billion US dollars of shares<blockquote>网易在盘前交易中上涨超过5%，因为该公司将回购高达30亿美元的股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNetease jumped over 5% in premarket trading as the company will repurchase up to 3 billion US dollars of shares<blockquote>网易在盘前交易中上涨超过5%，因为该公司将回购高达30亿美元的股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-16 17:01</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Netease jumped over 5% in premarket trading as the company&nbsp;will repurchase up to 3 billion US dollars of shares.<img src=\"https://static.tigerbbs.com/61e3152ea1cdeed59a202df6546c9326\" tg-width=\"769\" tg-height=\"565\" referrerpolicy=\"no-referrer\">NetEase's revenue in the third quarter was 22.2 billion yuan (RMB, the same below), a year-on-year increase of 18.9%; The net profit attributable to the mother was RMB 3.2 billion, up 6.1% year-on-year.</p><p><blockquote>网易在盘前交易中上涨超过5%，因为该公司将回购高达30亿美元的股票。网易第三季度营收为222亿元(人民币，下同)，同比增长18.9%；归母净利润32亿元，同比增长6.1%。</blockquote></p><p> In the third quarter, the net income of online game services was 15.9 billion yuan (about 2.5 billion US dollars), a year-on-year increase of 14.7%; The net income of NetEase Youdao (DAO) was 1.4 billion yuan, up 54.8% year-on-year.</p><p><blockquote>第三季度，网络游戏服务净营收为159亿元人民币（约合25亿美元），同比增长14.7%；网易有道（DAO）净收入14亿元，同比增长54.8%。</blockquote></p><p> At the same time,The board of directors has approved an increase in the amount of the share repurchase program to no more than $3 billion.</p><p><blockquote>与此同时， 董事会已批准将股票回购计划金额增加至不超过30亿美元。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09999":"网易-S","NTES":"网易"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1194227549","content_text":"Netease jumped over 5% in premarket trading as the company will repurchase up to 3 billion US dollars of shares.NetEase's revenue in the third quarter was 22.2 billion yuan (RMB, the same below), a year-on-year increase of 18.9%; The net profit attributable to the mother was RMB 3.2 billion, up 6.1% year-on-year.\nIn the third quarter, the net income of online game services was 15.9 billion yuan (about 2.5 billion US dollars), a year-on-year increase of 14.7%; The net income of NetEase Youdao (DAO) was 1.4 billion yuan, up 54.8% year-on-year.\nAt the same time,The board of directors has approved an increase in the amount of the share repurchase program to no more than $3 billion.","news_type":1,"symbols_score_info":{"09999":0.9,"NTES":0.9}},"isVote":1,"tweetType":1,"viewCount":1238,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":847290954,"gmtCreate":1636519870968,"gmtModify":1636519871283,"author":{"id":"4098068058321510","authorId":"4098068058321510","name":"BNX13","avatar":"https://static.tigerbbs.com/5d3344dbee36ba1a93ce6095b9a6a82b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098068058321510","idStr":"4098068058321510"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>🍎🍏","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>🍎🍏","text":"$Apple(AAPL)$🍎🍏","images":[{"img":"https://static.tigerbbs.com/cdc7055b683b2850ceb4526934460fa6","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/847290954","isVote":1,"tweetType":1,"viewCount":1074,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":847207065,"gmtCreate":1636519821700,"gmtModify":1636519821965,"author":{"id":"4098068058321510","authorId":"4098068058321510","name":"BNX13","avatar":"https://static.tigerbbs.com/5d3344dbee36ba1a93ce6095b9a6a82b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098068058321510","idStr":"4098068058321510"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/NVDA\">$NVIDIA Corp(NVDA)$</a>🤯","listText":"<a href=\"https://laohu8.com/S/NVDA\">$NVIDIA Corp(NVDA)$</a>🤯","text":"$NVIDIA Corp(NVDA)$🤯","images":[{"img":"https://static.tigerbbs.com/f7c30bfcef727c2bbf6374b7fdf47488","width":"1080","height":"2335"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/847207065","isVote":1,"tweetType":1,"viewCount":682,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":844225235,"gmtCreate":1636432885298,"gmtModify":1636432885619,"author":{"id":"4098068058321510","authorId":"4098068058321510","name":"BNX13","avatar":"https://static.tigerbbs.com/5d3344dbee36ba1a93ce6095b9a6a82b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098068058321510","idStr":"4098068058321510"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>🚀🌜","listText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>🚀🌜","text":"$Tesla Motors(TSLA)$🚀🌜","images":[{"img":"https://static.tigerbbs.com/5cb2cb792533c4b076f65339df2d1805","width":"1080","height":"2335"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844225235","isVote":1,"tweetType":1,"viewCount":1074,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":844225974,"gmtCreate":1636432842219,"gmtModify":1636432842506,"author":{"id":"4098068058321510","authorId":"4098068058321510","name":"BNX13","avatar":"https://static.tigerbbs.com/5d3344dbee36ba1a93ce6095b9a6a82b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098068058321510","idStr":"4098068058321510"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>🍎🍏🍎🍏❤❤❤❤","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>🍎🍏🍎🍏❤❤❤❤","text":"$Apple(AAPL)$🍎🍏🍎🍏❤❤❤❤","images":[{"img":"https://static.tigerbbs.com/a53d7160f95a401a6f3093b322f00668","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844225974","isVote":1,"tweetType":1,"viewCount":1031,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0}],"hots":[{"id":875893833,"gmtCreate":1637629959719,"gmtModify":1637629959820,"author":{"id":"4098068058321510","authorId":"4098068058321510","name":"BNX13","avatar":"https://static.tigerbbs.com/5d3344dbee36ba1a93ce6095b9a6a82b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098068058321510","idStr":"4098068058321510"},"themes":[],"title":"","htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/875893833","repostId":"1122322848","repostType":4,"isVote":1,"tweetType":1,"viewCount":3720,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877233849,"gmtCreate":1637933843875,"gmtModify":1637933844001,"author":{"id":"4098068058321510","authorId":"4098068058321510","name":"BNX13","avatar":"https://static.tigerbbs.com/5d3344dbee36ba1a93ce6095b9a6a82b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098068058321510","idStr":"4098068058321510"},"themes":[],"title":"","htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/877233849","repostId":"2186488363","repostType":4,"isVote":1,"tweetType":1,"viewCount":3377,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871629815,"gmtCreate":1637066315682,"gmtModify":1637066315988,"author":{"id":"4098068058321510","authorId":"4098068058321510","name":"BNX13","avatar":"https://static.tigerbbs.com/5d3344dbee36ba1a93ce6095b9a6a82b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098068058321510","idStr":"4098068058321510"},"themes":[],"title":"","htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/871629815","repostId":"1115914926","repostType":4,"repost":{"id":"1115914926","kind":"news","pubTimestamp":1637065849,"share":"https://www.laohunote.com/m/news/1115914926?lang=zh_CN&edition=full","pubTime":"2021-11-16 20:30","market":"us","language":"en","title":"Report says drugmakers impose unjustified U.S. price increases; spending on AbbVie drug rises $1.4 billion<blockquote>报告称制药商不合理地提高美国价格；艾伯维药物支出增加 14 亿美元</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1115914926","media":"Reuters","summary":"Drugmakers hiked U.S. prices on seven of the 10 costliest prescription drugs in 2020 without justifi","content":"<p>Drugmakers hiked U.S. prices on seven of the 10 costliest prescription drugs in 2020 without justification, increasing drug spending by $1.67 billion, a U.S. group that reviews the value of medicines said on Tuesday.</p><p><blockquote>一个审查药品价值的美国组织周二表示，制药商在没有正当理由的情况下提高了 2020 年 10 种最昂贵处方药中 7 种的美国价格，使药品支出增加了 16.7 亿美元。</blockquote></p><p> AbbVie Inc's(ABBV.N)widely used Humira rheumatoid arthritis drug accounted for the majority of the spending increase, with a net price increase of 9.6% leading to an almost $1.4 billion increase in U.S. spending.</p><p><blockquote>艾伯维公司(ABBV.N)广泛使用的Humira类风湿性关节炎药物占据了支出增长的大部分，净价格上涨9.6%，导致美国支出增加近14亿美元。</blockquote></p><p> The Boston-based Institute for Clinical and Economic Review (ICER) said in a report that after reviewing published studies and input from drug manufacturers it found no evidence of new clinical benefits to justify the price hikes.</p><p><blockquote>总部位于波士顿的临床和经济评论研究所（ICER）在一份报告中表示，在审查了已发表的研究和药品制造商的意见后，没有发现新的临床益处的证据来证明价格上涨是合理的。</blockquote></p><p> \"Several of these treatments have been on the market for many years, with scant evidence that they are any more effective than we understood them to be years ago when they cost far less,\" said ICER Chief Medical Officer David Rind.</p><p><blockquote>ICER 首席医疗官 David Rind 表示：“其中一些治疗方法已经上市多年，几乎没有证据表明它们比我们多年前所了解的更有效，当时它们的成本要低得多。”</blockquote></p><p> \"The most extreme of these is Humira, with an ever-escalating U.S. price that contrasts starkly to its falling price in every country where Humira currently faces biosimilar competition,\" he said in a statement. Humira received U.S. regulatory approval in 2002.</p><p><blockquote>他在一份声明中表示：“其中最极端的是修美乐，美国的价格不断攀升，与修美乐目前面临生物仿制药竞争的每个国家的价格不断下降形成鲜明对比。”Humira 于 2002 年获得美国监管部门批准。</blockquote></p><p> AbbVie said in a response to ICER that the report lacked context because ICER does not perform full value assessments and excludes evidence from smaller patient populations.</p><p><blockquote>艾伯维在回复 ICER 时表示，该报告缺乏背景信息，因为 ICER 不进行完整的价值评估，并且排除了来自较小患者群体的证据。</blockquote></p><p> The findings come as President Joe Biden and Democrats in Congress attempt to push through legislation that would lower drug prices by allowing the federal government to negotiate drug payments by Medicare, which covers Americans aged 65 and older.</p><p><blockquote>这些发现出炉之际，乔·拜登总统和国会民主党人试图通过立法，允许联邦政府通过医疗保险谈判降低药品价格，医疗保险覆盖65岁及以上的美国人。</blockquote></p><p> The United States spends more than twice as much per person on drugs as other wealthy economies, about $1,500, for a total of around $350 billion in 2019.</p><p><blockquote>美国人均药品支出是其他富裕经济体的两倍多，约为1500美元，2019年总额约为3500亿美元。</blockquote></p><p> Novartis(NOVN.S)drug Promacta, which is used to treat the rare blood disorder severe aplastic anemia (SAA), saw the highest increase in net price at 14.1%, leading to a $100 million increase in U.S. spending.</p><p><blockquote>诺华（NOVN.S）用于治疗罕见血液疾病严重再生障碍性贫血（SAA）的药物Promacta净价涨幅最高，达到14.1%，导致美国支出增加1亿美元。</blockquote></p><p> Novartis said it takes a value-based pricing approach and that it provided ICER with significant new clinical and health economic data that the group did not take into account.</p><p><blockquote>诺华表示，它采用基于价值的定价方法，并向 ICER 提供了该集团没有考虑的重要新临床和健康经济数据。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Report says drugmakers impose unjustified U.S. price increases; spending on AbbVie drug rises $1.4 billion<blockquote>报告称制药商不合理地提高美国价格；艾伯维药物支出增加 14 亿美元</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nReport says drugmakers impose unjustified U.S. price increases; spending on AbbVie drug rises $1.4 billion<blockquote>报告称制药商不合理地提高美国价格；艾伯维药物支出增加 14 亿美元</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Reuters</strong><span class=\"h-time small\">2021-11-16 20:30</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Drugmakers hiked U.S. prices on seven of the 10 costliest prescription drugs in 2020 without justification, increasing drug spending by $1.67 billion, a U.S. group that reviews the value of medicines said on Tuesday.</p><p><blockquote>一个审查药品价值的美国组织周二表示，制药商在没有正当理由的情况下提高了 2020 年 10 种最昂贵处方药中 7 种的美国价格，使药品支出增加了 16.7 亿美元。</blockquote></p><p> AbbVie Inc's(ABBV.N)widely used Humira rheumatoid arthritis drug accounted for the majority of the spending increase, with a net price increase of 9.6% leading to an almost $1.4 billion increase in U.S. spending.</p><p><blockquote>艾伯维公司(ABBV.N)广泛使用的Humira类风湿性关节炎药物占据了支出增长的大部分，净价格上涨9.6%，导致美国支出增加近14亿美元。</blockquote></p><p> The Boston-based Institute for Clinical and Economic Review (ICER) said in a report that after reviewing published studies and input from drug manufacturers it found no evidence of new clinical benefits to justify the price hikes.</p><p><blockquote>总部位于波士顿的临床和经济评论研究所（ICER）在一份报告中表示，在审查了已发表的研究和药品制造商的意见后，没有发现新的临床益处的证据来证明价格上涨是合理的。</blockquote></p><p> \"Several of these treatments have been on the market for many years, with scant evidence that they are any more effective than we understood them to be years ago when they cost far less,\" said ICER Chief Medical Officer David Rind.</p><p><blockquote>ICER 首席医疗官 David Rind 表示：“其中一些治疗方法已经上市多年，几乎没有证据表明它们比我们多年前所了解的更有效，当时它们的成本要低得多。”</blockquote></p><p> \"The most extreme of these is Humira, with an ever-escalating U.S. price that contrasts starkly to its falling price in every country where Humira currently faces biosimilar competition,\" he said in a statement. Humira received U.S. regulatory approval in 2002.</p><p><blockquote>他在一份声明中表示：“其中最极端的是修美乐，美国的价格不断攀升，与修美乐目前面临生物仿制药竞争的每个国家的价格不断下降形成鲜明对比。”Humira 于 2002 年获得美国监管部门批准。</blockquote></p><p> AbbVie said in a response to ICER that the report lacked context because ICER does not perform full value assessments and excludes evidence from smaller patient populations.</p><p><blockquote>艾伯维在回复 ICER 时表示，该报告缺乏背景信息，因为 ICER 不进行完整的价值评估，并且排除了来自较小患者群体的证据。</blockquote></p><p> The findings come as President Joe Biden and Democrats in Congress attempt to push through legislation that would lower drug prices by allowing the federal government to negotiate drug payments by Medicare, which covers Americans aged 65 and older.</p><p><blockquote>这些发现出炉之际，乔·拜登总统和国会民主党人试图通过立法，允许联邦政府通过医疗保险谈判降低药品价格，医疗保险覆盖65岁及以上的美国人。</blockquote></p><p> The United States spends more than twice as much per person on drugs as other wealthy economies, about $1,500, for a total of around $350 billion in 2019.</p><p><blockquote>美国人均药品支出是其他富裕经济体的两倍多，约为1500美元，2019年总额约为3500亿美元。</blockquote></p><p> Novartis(NOVN.S)drug Promacta, which is used to treat the rare blood disorder severe aplastic anemia (SAA), saw the highest increase in net price at 14.1%, leading to a $100 million increase in U.S. spending.</p><p><blockquote>诺华（NOVN.S）用于治疗罕见血液疾病严重再生障碍性贫血（SAA）的药物Promacta净价涨幅最高，达到14.1%，导致美国支出增加1亿美元。</blockquote></p><p> Novartis said it takes a value-based pricing approach and that it provided ICER with significant new clinical and health economic data that the group did not take into account.</p><p><blockquote>诺华表示，它采用基于价值的定价方法，并向 ICER 提供了该集团没有考虑的重要新临床和健康经济数据。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.reuters.com/business/healthcare-pharmaceuticals/report-says-drugmakers-impose-unjustified-us-price-increases-spending-abbvie-2021-11-16/\">Reuters</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ABBV":"艾伯维公司"},"source_url":"https://www.reuters.com/business/healthcare-pharmaceuticals/report-says-drugmakers-impose-unjustified-us-price-increases-spending-abbvie-2021-11-16/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1115914926","content_text":"Drugmakers hiked U.S. prices on seven of the 10 costliest prescription drugs in 2020 without justification, increasing drug spending by $1.67 billion, a U.S. group that reviews the value of medicines said on Tuesday.\nAbbVie Inc's(ABBV.N)widely used Humira rheumatoid arthritis drug accounted for the majority of the spending increase, with a net price increase of 9.6% leading to an almost $1.4 billion increase in U.S. spending.\nThe Boston-based Institute for Clinical and Economic Review (ICER) said in a report that after reviewing published studies and input from drug manufacturers it found no evidence of new clinical benefits to justify the price hikes.\n\"Several of these treatments have been on the market for many years, with scant evidence that they are any more effective than we understood them to be years ago when they cost far less,\" said ICER Chief Medical Officer David Rind.\n\"The most extreme of these is Humira, with an ever-escalating U.S. price that contrasts starkly to its falling price in every country where Humira currently faces biosimilar competition,\" he said in a statement. Humira received U.S. regulatory approval in 2002.\nAbbVie said in a response to ICER that the report lacked context because ICER does not perform full value assessments and excludes evidence from smaller patient populations.\nThe findings come as President Joe Biden and Democrats in Congress attempt to push through legislation that would lower drug prices by allowing the federal government to negotiate drug payments by Medicare, which covers Americans aged 65 and older.\nThe United States spends more than twice as much per person on drugs as other wealthy economies, about $1,500, for a total of around $350 billion in 2019.\nNovartis(NOVN.S)drug Promacta, which is used to treat the rare blood disorder severe aplastic anemia (SAA), saw the highest increase in net price at 14.1%, leading to a $100 million increase in U.S. spending.\nNovartis said it takes a value-based pricing approach and that it provided ICER with significant new clinical and health economic data that the group did not take into account.","news_type":1,"symbols_score_info":{"ABBV":0.9}},"isVote":1,"tweetType":1,"viewCount":984,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":845238796,"gmtCreate":1636339691839,"gmtModify":1636339916226,"author":{"id":"4098068058321510","authorId":"4098068058321510","name":"BNX13","avatar":"https://static.tigerbbs.com/5d3344dbee36ba1a93ce6095b9a6a82b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098068058321510","idStr":"4098068058321510"},"themes":[],"title":"","htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/845238796","repostId":"2181233137","repostType":4,"isVote":1,"tweetType":1,"viewCount":900,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":848836967,"gmtCreate":1635988067917,"gmtModify":1635988068122,"author":{"id":"4098068058321510","authorId":"4098068058321510","name":"BNX13","avatar":"https://static.tigerbbs.com/5d3344dbee36ba1a93ce6095b9a6a82b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098068058321510","idStr":"4098068058321510"},"themes":[],"title":"","htmlText":"Pls 👍","listText":"Pls 👍","text":"Pls 👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/848836967","repostId":"1189927565","repostType":4,"isVote":1,"tweetType":1,"viewCount":634,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876645820,"gmtCreate":1637312278645,"gmtModify":1637312278757,"author":{"id":"4098068058321510","authorId":"4098068058321510","name":"BNX13","avatar":"https://static.tigerbbs.com/5d3344dbee36ba1a93ce6095b9a6a82b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098068058321510","idStr":"4098068058321510"},"themes":[],"title":"","htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/876645820","repostId":"1199605105","repostType":4,"repost":{"id":"1199605105","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga Earnings","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1637311720,"share":"https://www.laohunote.com/m/news/1199605105?lang=zh_CN&edition=full","pubTime":"2021-11-19 16:48","market":"us","language":"en","title":"5 Stocks To Watch For November 19, 2021<blockquote>2021 年 11 月 19 日值得关注的 5 只股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1199605105","media":"Benzinga Earnings","summary":"Some of the stocks that may grab investor focus today are:\n\nWall Street expects Foot Locker, Inc. to","content":"<p>Some of the stocks that may grab investor focus today are:</p><p><blockquote>今天可能吸引投资者关注的一些股票是：</blockquote></p><p> <ul>  <li>Wall Street expects&nbsp;<b>Foot Locker, Inc.</b>&nbsp;to report quarterly earnings at $1.37 per share on revenue of $2.12 billion before the opening bell. Foot Locker shares rose 3.2% to $59.40 in after-hours trading.</li>  <li><b>Intuit Inc.</b>&nbsp;reported better-than-expected results for its first quarter and issued strong forecast for FY22. Intuit shares jumped 9% to $685.50 in the after-hours trading session.</li>  <li><b>Ross Stores, Inc.</b>&nbsp;reported upbeat earnings for its third quarter, but issued weak earnings guidance for the current quarter. Ross Stores shares dropped 5% to $113.5 in the after-hours trading session.</li> </ul> <ul>  <li>Analysts are expecting&nbsp;<b>The Buckle, Inc.</b>&nbsp;to have earned $0.92 per share on revenue of $299.12 million in the recent quarter. The company will release earnings before the markets open. Buckle shares rose 0.5% to $54.04 in after-hours trading.</li>  <li><b>Workday, Inc.</b>&nbsp;posted stronger-than-expected earnings for its third quarter and announced intent to acquire VNDLY for $510 million. The company also said it sees Q4 subscription revenue of $1.216 billion to $1.218 billion. Workday shares dipped 8% to $275.10 in the after-hours trading session.</li> </ul></p><p><blockquote><ul><li>华尔街预期<b>脚柜公司。</b>开盘前公布季度收益为每股 1.37 美元，营收为 21.2 亿美元。Foot Locker 股价在盘后交易中上涨 3.2%，至 59.40 美元。</li><li><b>直觉公司。</b>公布第一季度业绩好于预期，并发布了 2022 财年的强劲预测。Intuit 股价在盘后交易时段上涨 9%，至 685.50 美元。</li><li><b>罗斯商店公司。</b>报告第三季度盈利乐观，但发布了本季度疲软的盈利指引。Ross Stores 股价在盘后交易时段下跌 5%，至 113.5 美元。</li></ul><ul><li>分析师预计<b>带扣公司。</b>最近一个季度每股收益 0.92 美元，营收为 2.9912 亿美元。该公司将在开盘前发布财报。Buckle 股价在盘后交易中上涨 0.5%，至 54.04 美元。</li><li><b>工作日公司。</b>公布第三季度收益强于预期，并宣布有意以 5.1 亿美元收购 VNDLY。该公司还表示，预计第四季度订阅收入将达到 12.16 亿美元至 12.18 亿美元。Workday 股价在盘后交易时段下跌 8%，至 275.10 美元。</li></ul></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks To Watch For November 19, 2021<blockquote>2021 年 11 月 19 日值得关注的 5 只股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks To Watch For November 19, 2021<blockquote>2021 年 11 月 19 日值得关注的 5 只股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga Earnings </p>\n<p class=\"h-time smaller\">2021-11-19 16:48</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p>Some of the stocks that may grab investor focus today are:</p><p><blockquote>今天可能吸引投资者关注的一些股票是：</blockquote></p><p> <ul>  <li>Wall Street expects&nbsp;<b>Foot Locker, Inc.</b>&nbsp;to report quarterly earnings at $1.37 per share on revenue of $2.12 billion before the opening bell. Foot Locker shares rose 3.2% to $59.40 in after-hours trading.</li>  <li><b>Intuit Inc.</b>&nbsp;reported better-than-expected results for its first quarter and issued strong forecast for FY22. Intuit shares jumped 9% to $685.50 in the after-hours trading session.</li>  <li><b>Ross Stores, Inc.</b>&nbsp;reported upbeat earnings for its third quarter, but issued weak earnings guidance for the current quarter. Ross Stores shares dropped 5% to $113.5 in the after-hours trading session.</li> </ul> <ul>  <li>Analysts are expecting&nbsp;<b>The Buckle, Inc.</b>&nbsp;to have earned $0.92 per share on revenue of $299.12 million in the recent quarter. The company will release earnings before the markets open. Buckle shares rose 0.5% to $54.04 in after-hours trading.</li>  <li><b>Workday, Inc.</b>&nbsp;posted stronger-than-expected earnings for its third quarter and announced intent to acquire VNDLY for $510 million. The company also said it sees Q4 subscription revenue of $1.216 billion to $1.218 billion. Workday shares dipped 8% to $275.10 in the after-hours trading session.</li> </ul></p><p><blockquote><ul><li>华尔街预期<b>脚柜公司。</b>开盘前公布季度收益为每股 1.37 美元，营收为 21.2 亿美元。Foot Locker 股价在盘后交易中上涨 3.2%，至 59.40 美元。</li><li><b>直觉公司。</b>公布第一季度业绩好于预期，并发布了 2022 财年的强劲预测。Intuit 股价在盘后交易时段上涨 9%，至 685.50 美元。</li><li><b>罗斯商店公司。</b>报告第三季度盈利乐观，但发布了本季度疲软的盈利指引。Ross Stores 股价在盘后交易时段下跌 5%，至 113.5 美元。</li></ul><ul><li>分析师预计<b>带扣公司。</b>最近一个季度每股收益 0.92 美元，营收为 2.9912 亿美元。该公司将在开盘前发布财报。Buckle 股价在盘后交易中上涨 0.5%，至 54.04 美元。</li><li><b>工作日公司。</b>公布第三季度收益强于预期，并宣布有意以 5.1 亿美元收购 VNDLY。该公司还表示，预计第四季度订阅收入将达到 12.16 亿美元至 12.18 亿美元。Workday 股价在盘后交易时段下跌 8%，至 275.10 美元。</li></ul></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"WDAY":"Workday","INTU":"财捷","ROST":"罗斯百货有限公司","BKE":"巴克尔"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1199605105","content_text":"Some of the stocks that may grab investor focus today are:\n\nWall Street expects Foot Locker, Inc. to report quarterly earnings at $1.37 per share on revenue of $2.12 billion before the opening bell. Foot Locker shares rose 3.2% to $59.40 in after-hours trading.\nIntuit Inc. reported better-than-expected results for its first quarter and issued strong forecast for FY22. Intuit shares jumped 9% to $685.50 in the after-hours trading session.\nRoss Stores, Inc. reported upbeat earnings for its third quarter, but issued weak earnings guidance for the current quarter. Ross Stores shares dropped 5% to $113.5 in the after-hours trading session.\n\n\nAnalysts are expecting The Buckle, Inc. to have earned $0.92 per share on revenue of $299.12 million in the recent quarter. The company will release earnings before the markets open. Buckle shares rose 0.5% to $54.04 in after-hours trading.\nWorkday, Inc. posted stronger-than-expected earnings for its third quarter and announced intent to acquire VNDLY for $510 million. The company also said it sees Q4 subscription revenue of $1.216 billion to $1.218 billion. Workday shares dipped 8% to $275.10 in the after-hours trading session.","news_type":1,"symbols_score_info":{"WDAY":0.9,"BKE":0.9,"INTU":0.9,"ROST":0.9,"FL":0.9}},"isVote":1,"tweetType":1,"viewCount":2716,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":845238921,"gmtCreate":1636339612404,"gmtModify":1636339612642,"author":{"id":"4098068058321510","authorId":"4098068058321510","name":"BNX13","avatar":"https://static.tigerbbs.com/5d3344dbee36ba1a93ce6095b9a6a82b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098068058321510","idStr":"4098068058321510"},"themes":[],"title":"","htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/845238921","repostId":"2181284457","repostType":4,"isVote":1,"tweetType":1,"viewCount":526,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":845238108,"gmtCreate":1636339643358,"gmtModify":1636339643578,"author":{"id":"4098068058321510","authorId":"4098068058321510","name":"BNX13","avatar":"https://static.tigerbbs.com/5d3344dbee36ba1a93ce6095b9a6a82b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098068058321510","idStr":"4098068058321510"},"themes":[],"title":"","htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/845238108","repostId":"2181238097","repostType":4,"isVote":1,"tweetType":1,"viewCount":721,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875804233,"gmtCreate":1637629702255,"gmtModify":1637629702403,"author":{"id":"4098068058321510","authorId":"4098068058321510","name":"BNX13","avatar":"https://static.tigerbbs.com/5d3344dbee36ba1a93ce6095b9a6a82b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098068058321510","idStr":"4098068058321510"},"themes":[],"title":"","htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/875804233","repostId":"2185306806","repostType":4,"isVote":1,"tweetType":1,"viewCount":4048,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876644209,"gmtCreate":1637312431986,"gmtModify":1637312432133,"author":{"id":"4098068058321510","authorId":"4098068058321510","name":"BNX13","avatar":"https://static.tigerbbs.com/5d3344dbee36ba1a93ce6095b9a6a82b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098068058321510","idStr":"4098068058321510"},"themes":[],"title":"","htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876644209","repostId":"1199605105","repostType":4,"repost":{"id":"1199605105","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga Earnings","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1637311720,"share":"https://www.laohunote.com/m/news/1199605105?lang=zh_CN&edition=full","pubTime":"2021-11-19 16:48","market":"us","language":"en","title":"5 Stocks To Watch For November 19, 2021<blockquote>2021 年 11 月 19 日值得关注的 5 只股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1199605105","media":"Benzinga Earnings","summary":"Some of the stocks that may grab investor focus today are:\n\nWall Street expects Foot Locker, Inc. to","content":"<p>Some of the stocks that may grab investor focus today are:</p><p><blockquote>今天可能吸引投资者关注的一些股票是：</blockquote></p><p> <ul>  <li>Wall Street expects&nbsp;<b>Foot Locker, Inc.</b>&nbsp;to report quarterly earnings at $1.37 per share on revenue of $2.12 billion before the opening bell. Foot Locker shares rose 3.2% to $59.40 in after-hours trading.</li>  <li><b>Intuit Inc.</b>&nbsp;reported better-than-expected results for its first quarter and issued strong forecast for FY22. Intuit shares jumped 9% to $685.50 in the after-hours trading session.</li>  <li><b>Ross Stores, Inc.</b>&nbsp;reported upbeat earnings for its third quarter, but issued weak earnings guidance for the current quarter. Ross Stores shares dropped 5% to $113.5 in the after-hours trading session.</li> </ul> <ul>  <li>Analysts are expecting&nbsp;<b>The Buckle, Inc.</b>&nbsp;to have earned $0.92 per share on revenue of $299.12 million in the recent quarter. The company will release earnings before the markets open. Buckle shares rose 0.5% to $54.04 in after-hours trading.</li>  <li><b>Workday, Inc.</b>&nbsp;posted stronger-than-expected earnings for its third quarter and announced intent to acquire VNDLY for $510 million. The company also said it sees Q4 subscription revenue of $1.216 billion to $1.218 billion. Workday shares dipped 8% to $275.10 in the after-hours trading session.</li> </ul></p><p><blockquote><ul><li>华尔街预期<b>脚柜公司。</b>开盘前公布季度收益为每股 1.37 美元，营收为 21.2 亿美元。Foot Locker 股价在盘后交易中上涨 3.2%，至 59.40 美元。</li><li><b>直觉公司。</b>公布第一季度业绩好于预期，并发布了 2022 财年的强劲预测。Intuit 股价在盘后交易时段上涨 9%，至 685.50 美元。</li><li><b>罗斯商店公司。</b>报告第三季度盈利乐观，但发布了本季度疲软的盈利指引。Ross Stores 股价在盘后交易时段下跌 5%，至 113.5 美元。</li></ul><ul><li>分析师预计<b>带扣公司。</b>最近一个季度每股收益 0.92 美元，营收为 2.9912 亿美元。该公司将在开盘前发布财报。Buckle 股价在盘后交易中上涨 0.5%，至 54.04 美元。</li><li><b>工作日公司。</b>公布第三季度收益强于预期，并宣布有意以 5.1 亿美元收购 VNDLY。该公司还表示，预计第四季度订阅收入将达到 12.16 亿美元至 12.18 亿美元。Workday 股价在盘后交易时段下跌 8%，至 275.10 美元。</li></ul></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks To Watch For November 19, 2021<blockquote>2021 年 11 月 19 日值得关注的 5 只股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks To Watch For November 19, 2021<blockquote>2021 年 11 月 19 日值得关注的 5 只股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga Earnings </p>\n<p class=\"h-time smaller\">2021-11-19 16:48</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p>Some of the stocks that may grab investor focus today are:</p><p><blockquote>今天可能吸引投资者关注的一些股票是：</blockquote></p><p> <ul>  <li>Wall Street expects&nbsp;<b>Foot Locker, Inc.</b>&nbsp;to report quarterly earnings at $1.37 per share on revenue of $2.12 billion before the opening bell. Foot Locker shares rose 3.2% to $59.40 in after-hours trading.</li>  <li><b>Intuit Inc.</b>&nbsp;reported better-than-expected results for its first quarter and issued strong forecast for FY22. Intuit shares jumped 9% to $685.50 in the after-hours trading session.</li>  <li><b>Ross Stores, Inc.</b>&nbsp;reported upbeat earnings for its third quarter, but issued weak earnings guidance for the current quarter. Ross Stores shares dropped 5% to $113.5 in the after-hours trading session.</li> </ul> <ul>  <li>Analysts are expecting&nbsp;<b>The Buckle, Inc.</b>&nbsp;to have earned $0.92 per share on revenue of $299.12 million in the recent quarter. The company will release earnings before the markets open. Buckle shares rose 0.5% to $54.04 in after-hours trading.</li>  <li><b>Workday, Inc.</b>&nbsp;posted stronger-than-expected earnings for its third quarter and announced intent to acquire VNDLY for $510 million. The company also said it sees Q4 subscription revenue of $1.216 billion to $1.218 billion. Workday shares dipped 8% to $275.10 in the after-hours trading session.</li> </ul></p><p><blockquote><ul><li>华尔街预期<b>脚柜公司。</b>开盘前公布季度收益为每股 1.37 美元，营收为 21.2 亿美元。Foot Locker 股价在盘后交易中上涨 3.2%，至 59.40 美元。</li><li><b>直觉公司。</b>公布第一季度业绩好于预期，并发布了 2022 财年的强劲预测。Intuit 股价在盘后交易时段上涨 9%，至 685.50 美元。</li><li><b>罗斯商店公司。</b>报告第三季度盈利乐观，但发布了本季度疲软的盈利指引。Ross Stores 股价在盘后交易时段下跌 5%，至 113.5 美元。</li></ul><ul><li>分析师预计<b>带扣公司。</b>最近一个季度每股收益 0.92 美元，营收为 2.9912 亿美元。该公司将在开盘前发布财报。Buckle 股价在盘后交易中上涨 0.5%，至 54.04 美元。</li><li><b>工作日公司。</b>公布第三季度收益强于预期，并宣布有意以 5.1 亿美元收购 VNDLY。该公司还表示，预计第四季度订阅收入将达到 12.16 亿美元至 12.18 亿美元。Workday 股价在盘后交易时段下跌 8%，至 275.10 美元。</li></ul></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"WDAY":"Workday","INTU":"财捷","ROST":"罗斯百货有限公司","BKE":"巴克尔"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1199605105","content_text":"Some of the stocks that may grab investor focus today are:\n\nWall Street expects Foot Locker, Inc. to report quarterly earnings at $1.37 per share on revenue of $2.12 billion before the opening bell. Foot Locker shares rose 3.2% to $59.40 in after-hours trading.\nIntuit Inc. reported better-than-expected results for its first quarter and issued strong forecast for FY22. Intuit shares jumped 9% to $685.50 in the after-hours trading session.\nRoss Stores, Inc. reported upbeat earnings for its third quarter, but issued weak earnings guidance for the current quarter. Ross Stores shares dropped 5% to $113.5 in the after-hours trading session.\n\n\nAnalysts are expecting The Buckle, Inc. to have earned $0.92 per share on revenue of $299.12 million in the recent quarter. The company will release earnings before the markets open. Buckle shares rose 0.5% to $54.04 in after-hours trading.\nWorkday, Inc. posted stronger-than-expected earnings for its third quarter and announced intent to acquire VNDLY for $510 million. The company also said it sees Q4 subscription revenue of $1.216 billion to $1.218 billion. Workday shares dipped 8% to $275.10 in the after-hours trading session.","news_type":1,"symbols_score_info":{"WDAY":0.9,"BKE":0.9,"INTU":0.9,"ROST":0.9,"FL":0.9}},"isVote":1,"tweetType":1,"viewCount":3034,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}